1. Mar 2026
    1. On 2021-05-05 01:53:26, user philiptzou wrote:

      Questions:

      • Table 2, should the IC90 of WA isolate be 0.017?
      • Table 3B, what's the definition of B.1.351.v1, P.1.v1, P.1.v2, B.1.526.v2?
      • Table 5: should the pseudovirus IC50 of Wuhan strain be 0.003? Because according to K444Q and V445A, the closest control IC50 is 0.0028 (0.25/90 ? 0.227/82 ? 0.0028).
      • Table 6: The pseudovirus IC50 of Wuhan strain is inconsistence to the fold of K444Q and V445A. 0.25/20 is 0.0125 which is far from 0.003.
    1. On 2021-05-29 03:00:00, user Iris Young wrote:

      The preprint "Reciprocalspaceship: A Python Library for Crystallographic Data Analysis" describes a very welcome new lightweight tool for crystallographic data exploration and visualization. I'm excited about it for a number of reasons: it is intuitive and very quick to pick up, especially for users familiar with gemmi and pandas; it has documentation (!); it is a python3 library, with data objects interoperable with data visualization packages like matplotlib; and it is a permissively licensed, open-source package available on github. I can already imagine use cases for exploring unusual datasets in great depth.

      My only suggestions for improvement of the reciprocalspaceship library itself are things it does not yet do, but very soon could. The ability to explore the raw data is extremely powerful. My most ambitious ask is a very simple GUI for direct visualization of reflections in reciprocal space, similar to the Phenix reciprocal space viewer. Other, smaller things could be less than a day's work: the tutorial walks through calculations such as CC1/2, which could easily be incorporated into the library's algorithms. I would suggest adding CC* as well for purposes of outlier detection, and for exploration of possible misindexing, a little more scaffolding could go a long way. (I am not sure what the "reindex" method does yet, which possibly already addresses this, as it is missing from the documentation.)

      Regarding the preprint, it is an excellent introduction to the capabilities of the library. This is exactly what a preprint should be, and all the linked resources are in good shape for beta testing. I note some difficulties reading the equations, mainly due to a great number of variables that are never defined. I also encountered less common mathematical symbols (the delta-equal, which could be written out as a "let" statement), ambiguous ones (the hat on mu-hat), and notation that is simply visually dense (the use of overbars to denote means inside fractions, which might be alternatively denoted with angle brackets). With some attention to the equations, this will be a highly readable paper.

      The process of reviewing this preprint has already given me enough of an opportunity to familiarize myself with reciprocalspaceship and to convince myself of its merits that I expect to be using it routinely from now on. Thank you to the developers for both the tool and the manuscript!

      Minor points:<br /> - Figure 4 looks to be aggressively carved. The carving settings should be noted in the figure legend and should perhaps be a little more lenient in order to contextualize the size of the features shown, if this does not add excessive clutter.<br /> - The alpha parameter is mentioned in passing, with just enough detail to raise questions. Could this be expanded on just a bit?<br /> - PyMOL should be included in the references.<br /> - There is a typo in "The data [were] merged using Student's t-distributions"

      Iris Young (Fraser Lab, UCSF)

    1. On 2016-05-19 13:47:17, user Javier Quílez wrote:

      In Supp. Figure 3 I understand your point is that, sort to speak, the GO trees are getting longer branches and thus being more specific. If so, I think it would better read as "Histogram shows the number of steps...". Otherwise it may be confused with the point in Supp. Figure 4.

    1. On 2019-06-11 13:35:43, user Hu Chuan-Peng wrote:

      Dear Dr. Hu,<br /> Thank you for submitting your manuscript to the journal. I regret to inform you that the journal is unable to publish you paper based on the comments raised by the reviewers.<br /> Please refer to the comments listed at the end of this letter.

      We appreciate your submitting your manuscript to this journal and for giving us the opportunity to consider your work.

      Kind regards,

      Associate Editor

      Comments from reviewers:<br /> -Reviewer 1<br /> The authors present an analysis of very heterogeneous approaches to the investigation of "beauty", including "brain activities elicited by beautiful stimuli", "beauty ratings", "preference". They justify this approach by saying that if a "common beauty center" in the brain is found, then it was identified /even though/ the experimental approaches used were very different: "This definition [of beauty] can suit our purpose, i.e., synthesizing the current neuroaesthetic literature to search the "beauty center" in the brain. We assumed that if there are convergent results based on all laboratory studies in which subjective definitions were used, the results would at least suggest a common neural basis for the subjective experience of beauty" (p. 5). I agree that this approach would have been valid -- but only IF a common beauty center would have been found. However, such a center was not found, and thus the results cannot be interpreted in any useful way: It is not possible now to determine if the findings of different clusters for visual art and faces are due to the fact that faces vs. visual art were investigated, or due to other methodological differences (beauty ratings, feelings of beauty, preference, etc.).

      Along the same line, please explain what "experience of beauty" refers to (p. 4 and other parts of the ms) -- is it the "feeling of beauty", or a judgement of beauty, or both, or something else? The authors seem to be aware that the feeling of beauty can be independent of an aesthetic judgement (e.g., I might be able to judge something as beautiful, but not experience a "feeling of beauty" in that moment, e.g. because it is not the right situtation for the consumption of this piece of art, see e.g. Scherer's "production rules", see also the cited Menninghaus-article on aesthetic emotions).

      The English has to be improved massively throughout the ms. E.g. "recent studies have shown that the right inferior parietal lobe engaged in processing"; "used the conjunction analysis to find the commen the brain regions", "the results of single neuroimaging study may suffer", "previous studies used aesthetic stimuli varied in great degree", and many other occurrences.

      -Reviewer 2

      The authors of the present study investigated the neural basis of experiencing beauty of faces and visual art using an ALE meta-analysis and contrast analysis method. They report some convergent brain activation for the two domains under investigation, separately. They do also report, however, that there was no common neural basis for experiencing beauty in these two domains. This is an interesting study. I have a number of comments.

      Neural networks subserving mental processes are configured dynamically. When the mental processing changes, the brain network does, too. (Of course, only if these changes in mental processes are significant and matter for the brain.) When experimenters give their participants tasks to perform, they expect the mental processes of the participants to 'comply' with the instruction. They also do expect the resulting brain activation to be elicited by the (intended) mental processing. If studies on the experience on the aesthetic experience of beauty differ in the intended mental processing, as reflected in the instructions given to participants, in the mental processing mode expected participants to engage in, the resulting brain activation is likely to be different. Studies looking for common denominators of certain mental processing, like aesthetic appreciation of beauty should, therefore, employ very careful task analysis. If only one parameter is manipulated, the resulting subserving network can be attributed to that parameter. For example, Kornisheva et al. (2010, Human Brain Mapping) have employed a structurally equivalent experimental design to the cited study by Jacobsen and colleagues (2006, NeuroImage). They have altered the stimulus domain, switching from vision to audition, and using musical stimuli instead of visual graphic patterns. Using structurally equivalent descriptive and evaluative judgment tasks allowed the authors to identify neural substrate that is common to the aesthetic judgment of beauty, and activation which is domain specific. (Somewhat comparable to the later (cited) study by a Ishizu and Zekisick. It is mandatory, in my view, to exert careful task analysis in order to have an idea which mental process is precisely looked at. The authors of the present study do some thing in this regard, in providing a operational definition of the mental process saying they are interested in. This definition, however, is relatively vague it does not exert the precision of the above mentioned studies. Also the inclusion criteria for studies into the meta-analysis are either not fully clear, or have not been used in a rigorous manner. Beauty does not seem to have been a strict criterion when it came to selection of studies. A recommendation task is different from a gaze direction task, a pleasantness judgment, a preference rating, an observation task, a familiarity judgment, an animacy rating, or other mentioned tasks. A judgment task is different from a contemplation task. Also, stimuli and tasks may elicit highly differential reward and affective engagement of the beholder, again affecting brain network configuration. To analyze this thoroughly would also be part of task analysis, which would then reveal whether or not to expect overlap in the first place. <br /> Of course, looking for common activations elicited by beauty, regardless of task, would potentially be an interesting endeavour. For this, external beauty criteria would have to be included in the analysis, the subjectivity criterion abandoned.

      There are a number of typos throughout the text which need to be corrected.

      In sum, task analysis and proper execution of precise inclusion criteria may be used to render the present study a good contribution to the literature.

    1. On 2021-05-27 18:13:47, user elisafadda wrote:

      The following is my peer review. Again, congratulations to the authors on this great work.

      "In this manuscript the authors present the results of an exceptional study of the deglycosylation of IgG Fc-glycans by<br /> Endo S2, generating and examining an impressive set of catalytically-competent complexes between an IgG Fc and Endo-S2. In this work, different molecular simulations approaches have been integrated harmoniously and performed successfully,<br /> in my opinion, to provide us with much needed insight into the Endo-S2 enzymatic activity. I truly enjoyed reading the manuscript and first and foremost would like to congratulate the authors on the work. I also would like to bring up the following few points and make some suggestions that the authors may find useful to consider and that I think may help bring the results<br /> together into a potential mechanism.

      As the authors are aware, in isolated IgGs the two Fc-glycans are tightly packed within the Fc “horseshoe” structure, with each arm (considering complex N-glycans in human IgG1 for example)<br /> extending on either side of the Fc (see Harbison and Fadda, Glycobiology (2020) doi: https://doi.org/10.1093/gly... "https://doi.org/10.1093/glycob/cwz101)").<br /> The crystal structure of the Endo-S2 in complex with the N-glycan was obtained with isolated N-glycans, i.e. not bound to the Fc. In view of this interactions, I believe, or as a general choice of strategy, molecular docking was used as the first step in making the models, by docking isolated N-glycans and then linking the Fc, if I understood correctly. Because the whole N-glycans<br /> do not extend at the sides of the Fc, so are not exposed, yet, as I mentioned earlier, extend across the Fc, I was wondering if the authors noticed in any of their simulations the interaction of only one of the arms on either glycans with the CBM that could potentially initiate extraction. More specifically, if the<br /> 1-6 on the CH2-CH3 side facing the domain interacts with the CBM, it could potentially trigger the opening/loosening of the Fc structure, increasing the accessibility to both glycans and promoting the binding of the whole glycan to the CBM and of the other glycan to the GH. This scenario would agree with model<br /> D, where the CBM acts as a ‘grip’ facilitating the removal of the opposite N-glycan by GH. The second deglycosylation event could occur according to model C, where the N-glycan bound to the CBM could be ‘transferred’ to the GH, which I found fascinating!

      I understand that the above is a mechanistic speculation, yet a plausible one based on the evidence presented and in the literature, in my opinion, unifying all the different scenarios the<br /> authors examined and could be presented in the discussion. In any case, I think it would be useful to comment on how the N-glycans are potentially extracted from within the Fc to bind the CBM and GH.

      As minor points,

      I find that it would be really helpful to have Figures presenting the structures of the complexes in the main manuscript, indicating the positions/contacts of the glycans with CBM and GH in<br /> different models. Those could be integrated in Figure 1.

      Page 10 and throughout<br /> “long-time” MD simulations is probably not a specific term, consider multi-microsecond MD simulations or MD simulations in the low microsecond time range.

      Table 2 caption, “fist glycan” typo

      Page 12, “S2A to D Fig.” probably better as “Fig. S2A to D.”

      Figure 3 caption, the following sentence is unclear to me, please consider revising “Dashed lines indicate....”

      Page 17, “an increase in ~400 Ŕ units needs to be<br /> squared.

    1. On 2021-05-26 02:14:06, user ah3881 wrote:

      The premise of this is wrong. It is not language barriers, it is international coordination and collaboration barriers. Any migratory species with a wide range will necessarily be challenging to conserve, transboundary and transnational collaboration is difficult. For marine wading species (i.e. the EAAF) some species show population declines of 79%, due to a loss of coastal wetland, much of this is Thai and Korean-but language is not the issue here (the value of the land is). I imagine if you looked at birds across the Americas, or Africa (shared languages) their threat would be soley due to value of prime habitats, and would not compare to language. Furthermore, even across areas like Central Asia (where Russian is a shared language) political barriers will continue to be the prime barrier, not language. Other factors need to be explored in this context, it does not collapse down to language

    1. On 2018-02-22 10:15:24, user Roman wrote:

      It seems to me that the interpretation of Figure 3 in the text is not entirely correct. The first paragraph on page 7 states that SAMtools called more SNPs than other callers. In the absence of a plot, which would have been helpful by the way, the readers can only try to estimate that. The high number of calls is achieved when FNR is low and FDR is high compared to the other callers. However, SAMtools exhibit the opposite for WGS: high FNR and low FDR. Hence, it cannot call the most number of SNPs in the WGS dataset. Considering very high FNR for WES, SAMtools is also very unlikely to call the most number of SNPs in the WES dataset.

      In case of WGS SNP calling, SAMtools showed the best conservative performance (lowest FDR and low FNR) while GATK UG exhibited the best sensitive performace (lowest FNR and low FDR). This leaves GATK HC in the third place. Hence, you cannot make a blanket statement that "in contrast" to other algorithms GATK HC has high sensitivity and low FDR. It is clearly better for indel calling but for SNP calling the results are mixed.

      The second paragraph on page 7 claims "exceptionally high genotype concordance". Considering that GATK UG is fairly close and Platypus is not that far behind, I don't think that qualifies as "exceptional".

      The second paragraph on page 9 states that SAMtools has the highest sensitivity (reference to Figure 3 is missing). However, Figure 3 shows the highest FNR for SAMtools, which suggests exactly the opposite. Also, SAMtools has the lowest FDR for GWS. That also means that the results in Figure 3 are not consistent with the other studies.

      Minor note for the first sentence of the paragraph 1 on page 7: "HaplotypeCaller effectively calls" means that it can produce calls rather than that it shows good performance.

    1. On 2020-06-09 20:51:18, user JSRosenblum wrote:

      Please someone review this paper that knows that XMD8-92 is a bromodomain inhibitor, and that bromodomain inhibitors have numerous profound biological activities. Please... There are way better ERK5 inhibitors available, BAY-885 (which you can get for free from SGC!) and AX15836...

    1. On 2020-01-17 13:54:38, user Erika H wrote:

      Hi! This is an awesome study, and a great read. Cool to see more and more studies published using ASVs/ESVs in lieu of traditional OTUs.

      However, there was one mistake in the pre-print that sort of jumped out at me. In this line: "Briefly, the V3-V4 region was amplified using primers 515F-Y/926R (Parada et al. 2016) followed by library preparation (2 × 300 bp) and sequencing on a MiSeq Illumina platform."

      If the primers being used are from 515/926, the region amplified is actually V4-V5 not V3-V4.

      Best,

      E

    1. On 2016-04-25 17:09:12, user Phil Davis wrote:

      Your paper includes a summary of your findings by journal (Supplementary Table 1) but no list of the individual papers that contain image duplication. If readers are to trust the scientific record, this list will need to be made public. Some publishers have very specific policies about image manipulation in gels and blots and will take action to correct the scientific record.

    1. On 2019-09-24 02:02:00, user Fraser Lab wrote:

      The major goal of this paper is to put electron density maps on an absolute scale. Ideally, this would rid the world of “sigma” scaling and allow for electron density contours to take on a meaning that could map between different datasets or even over the course of refinement. This is also something that has been attempted previously, most notably (and with obvious conflict of interest on our end) by Lang...Alber, PNAS, 2014. Other important papers that have similar elements include the computational analysis by Shapovalov and Dunbrack, Proteins, 2009 (which examines the relationship between density, atom-type, and B-factor see Fig 4) and experimental work by Brian Matthews (Quillin PNAS 2004 and Liu PNAS 2006, reviewed in https://www.ncbi.nlm.nih.go... "https://www.ncbi.nlm.nih.gov/pubmed/19241368)"). What is exciting about this work is that it is a fresh start to the problem and it is optimistic that structural biologists and other users are eager for an “absolute scale”. However, the major reservations that we have about this paper are that it fails to build on or incorporate some of the lessons of these papers:

      For example - we think they are downloading 2mFo-DFc maps, but fail to account for FOM weighting to get an absolute scale - see Matthews work for a guide on how to do this. The F000 corrections they outline are missing the bulk solvent contribution - this is tricky and dealt with in the Lang/Alber paper. Their B-factor normalization scheme is difficult to follow and seems ad hoc, whereas the Dunbrack paper at least outlines a relationship to the physical meaning of B-factor to accomplish a similar normalization. Finally, when recalculating Fo-Fc maps (or mFo-DFc maps after accounting for FOM weighting), there is no need to normalize as it is already on an absolute scale when “volume” scaling is applied in phenix or (I recall) by default in REFMAC.

      Moreover, despite developing a method to convert electron density values into units of electrons the examples are all based on comparisons within a map where the rank order of strength of voxels does not change. While we applaud their idealism to move the community, an absolute scale is just part of the move beyond sigma scaling, we also need to think about a “confidence” metric (the RAPID part of the Lang paper or the EDIA metric in Meyder et al 2017 that they did not really respond to in the previous review or Beckers et al IUCRJ 2019 for an interesting alternative approach). We haven't reviewed the code, but it is really great that they have put their code up on github and it appears well documented.

      Minor point: The authors switch between using “chain deviation fraction” “chain fraction”, “chain density ratio”, median chain deviation fraction, median chain density ratio, chain median, median of chain density ratio, etc...

      We review non-anonymously, James Fraser and Roberto Efrain Diaz (UCSF)

    1. On 2025-10-24 06:27:05, user Prof. T. K. Wood wrote:

      Retrons are toxin/antitoxin systems. Please cite the first seminal study showing TAs are anti-phage systems: doi: 10.1128/jb.178.7.2044-2050.1996.

      How certain are you of 'cell death'?

    1. On 2016-06-23 20:41:36, user Peter Ellis wrote:

      I second Yoav Gilad's comment. The normalisation procedures involved in microarray analysis inherently mean that transcript abundances are measured as a fraction of the total RNA population and NEVER CAN give information on absolute transcript abundance. It is therefore virtually certain that a large proportion of the findings simply relate to differential stability of mRNA molecules. The fact that total RNA content dropped precipitously after 12 hours indicates that the rate of RNA degradation and loss is vastly greater than any new transcription.

      On a technical note - the authors give RNA concentrations "per ul of tissue extract". This is inappropriate given that an unspecified amount of tissue was lysed in a fixed volume of lysis buffer. If the liver biopsy from mouse 1 happened to be 10% larger than that from mouse 2, more RNA will be extracted, but that does not indicate increased transcriptional activity in mouse 2!

      However, even given the above notes, it is possible that they have observed a signature of active transcription of some genes. Is this surprising? Not at all. Just because the organism (fish or mouse) is dead, that does not mean every cell is dead - that's how transplants work! An organism at the point of death is comprised of cells, the vast majority of which are still alive, transcribing genes and doing whatever those cells normally do. Over subsequent days, all those cells will gradually die, in large part from hypoxic stress because the heart is no longer supplying the cells with oxygen. Upregulation of genes associated with hypoxia and apoptosis is thus anticipated, and tells us no more than if you'd put a dish of cultured cells in a low oxygen environment.

      Moreover, some cell types will survive better than others. When circulation stops, cells with a high energetic demand like brain cells will die faster than resting cells (e.g. fibroblasts) that require less energy. I've even heard anecdotes of fibroblast cell lines being recovered from freshly-made sausages! Cells that are adapted for free living such as sperm will survive especially well - I personally know people that have performed IVF using sperm from the epididymis of a male that died and was kept in the fridge over the weekend.

      Ergo, if you sample a tissue (with a mix of cell types) after organismal death, it will gradually lose the transcripts from the more vulnerable cell types, and there will be apparent upregulation of the transcripts from more resistant cell types (since they now form a greater proportion of the total). This again is as expected, and tells us no more - in fact considerably less - than you would find out by doing a detailed histological study of the tissues concerned and looking at how well the different cell types are surviving.

      The results of this study therefore represent a hopelessly confounded mish-mash of three factors: <br /> 1) the actual transcriptional events associated with cell death occurring within the body of a deceased animal.<br /> 2) systematic skewing of the results as different cell types within a tissue succumb to cell death at different rates.<br /> 3) systematic skewing of the results as transcripts within dead cells are degraded at different rates.

      There are better ways of looking into each of these factors.

      Edit to add - just thought of a fourth confounding factor, which is the purely physical processes affecting a cadaver. This one is more relevant to the mouse study than the fish one. In a dead body, there is a process of postmortem hypostasis (livor mortis) where the blood pools under the influence of gravity. Given that the liver stores a large proportion of the body's total blood supply, I would not be at all surprised to see the liver transcriptome appear to change as the blood drains out of it.

      Was there a clinical pathologist and/or histopathologist associated with this study? It seems to me that understanding the biochemical signals you observe has to be rooted in biological observations of the cellular events occurring in the sampled tissues.

    1. On 2017-07-10 14:25:52, user Luca Pinello wrote:

      We want to clarify that the preceding comment from Fafner Normanko is a critique of the original Schaefer et al article (https://www.nature.com/nmet... "https://www.nature.com/nmeth/journal/v14/n6/full/nmeth.4293.html)"), which is the paper our biorXiv manuscript is a response to. That is, wherever Fafner Normanko mentions "this paper" or "the authors" in this comment (which is actually a word-for-word repost made by Xiaolin Wu (https://www.ncbi.nlm.nih.go... "https://www.ncbi.nlm.nih.gov/pubmed/28557981/#comments)"), this is a reference to the Schaefer et al. paper or authors and not our biorXiv response to their article.

    1. On 2025-02-05 14:46:01, user Prof. T. K. Wood wrote:

      First paragraph is misleading as toxin/antitoxin systems have known to inhibit phage for almost 3 decades so instead of citing a review, the original seminal report should be cite: doi: 10.1128/jb.178.7.2044-2050.1996

    1. On 2022-08-31 11:17:49, user Nándor Lipták wrote:

      Dear Authors,

      In our previous study, we found mosaicism in founder (F0) rabbits, generated by CRISPR/Cas9 gene editing:<br /> doi: 10.3390/app10238508

      It is also a common phenomenon in CRISPR/Cas9 gene edited mice.

      Have you also detected mosaicism in your founder rabbits?

    1. On 2020-07-04 09:20:51, user Antonio Cassone wrote:

      We detected and reported on D614G mutation of SARS-2-CoV genome in Italian isolates , proposing the same interpretation about its functional value (enhanced virus transmission) based on biostrctural S1 change( ; see Benvenuto et al. Evidence for Mutations in SARS-CoV-2 Italian Isolates Potentially Affecting Virus Transmission J.Med.Virol., 2020, Jun 3:10.1002/jmv.26104. doi: 10.1002/jmv.26104.) We congratulate the Authors for providing direct evidence supporting D614G their and our own interpretation.

    1. On 2022-01-20 16:24:22, user David Curtis wrote:

      When you state that rs59185462 is associated with rheumatoid arthritis it might be helpful to point out that this variant is in the HLA region and that it is well established that particular HLA alleles have strong effects on risk of rheumatoid arthritis. The obvious explanation is that the observed association with rs59185462 is a consequence of it being in LD with causative HLA alleles.

    1. On 2024-06-04 17:49:18, user phillip kyriakakis wrote:

      Cool paper!

      A few thoughts:

      1) It would be great to see how this compares to the PhyB-PIF version<br /> 2) Blue light should activate PhyB/PhyA, it would be great to see different blue light doses to see how sensitive it is to blue light, not if it is sensitive to blue light. (See "Multi-chromatic control of mammalian gene expression and signaling" and "Multichromatic Control of Signaling Pathways in Mammalian Cells")<br /> 3) I am not sure what biological replicates means. Where three independent experiments done, or just three biological replicates, one experiment? If a single experiment, this should be made explicit and perhaps written as N = 1.<br /> 4) PhyA could be written as PhyA-NT instead of delta. Delta implies it is a knock out or something. Peter Quail used the "NT" notation and that has been used a lot since, so it would be easy for others to follow. <br /> 5) What are the effects of far-red light, perhaps with and without blue light? (See "Multi-chromatic control of mammalian gene expression and signaling" and "Multichromatic Control of Signaling Pathways in Mammalian Cells")<br /> 6) Would be nice to see blue and red systems multiplexed. Perhaps using DRE as in "Efficient photoactivatable Dre recombinase for cell type-specific spatiotemporal control of genome engineering in the mouse"

      I am not suggesting these experiments or changes are needed to be published, but could improve the usefulness.

    1. On 2021-03-09 00:43:51, user Jacob Matiyevsky wrote:

      In our recent research journal club, my colleagues and I chose to discuss your paper and we found it to be extremely interesting. I thought that overall your work did an excellent job at elucidating TAK1’s role in retinal neovascularization and showing that it’s inhibition could be a potential therapy for retinopathy. Each of my colleagues focused on a particular aspect of your paper in-depth, and my focus was on the studies done with OIR rats. I really enjoyed how your team looked at a wide range of effects stemming from TAK1 inhibition. That being said, we found ourselves craving a more comprehensive interpretation for the vaso-obliteration data in figure 7C and what you might have hoped to see with oxozeaenol injections in that case. In general, it might also be helpful to provide additional commentary on the importance of the differing results between the low and high oxozeaenol treatments across the effects you tested for readers to better understand which dose might be better. Also, in figure 6A I noticed that the hyperoxic level was illustrated to be 75%, but based on the rest of your paper I believe that was meant to be 80%. Finally, we thought that the use of immunostaining for the microglial adhesion assay was fantastic and the interpretation for it was extremely strong. We thought that perhaps doing something similar in figure 1 to characterize TAK1 expression in the human retina would strengthen your claim regarding high levels of TAK1 expression there.

    1. On 2020-04-21 02:25:55, user Sinai Immunol Review Project wrote:

      Main Findings:<br /> This study reports the identification of in-silico screened epitopes capable of binding MHCI (CTL), MHCII (HTL), and B cells with high immunogenicity that can be formulated with Ochocerca volvulus activation-associated secreted protein-1 (Ov-ASP-1) adjuvant into two multi-epitope vaccines (MEVs) for SARS-CoV-2. CTL, HTL, and B cell linear epitopes were identified, scored, and percentile-ranked utilizing respective IEDB server tools. SARS-CoV-2 polyprotein, surface (S) glycoprotein, envelope (E) protein, membrane (M) protein, nucleocapsid (N) protein, and several open reading frame proteins were screened in silico for potential CTL, HTL, and B cell epitopes. CTL epitopes were identified by the “MHC-I Binding Predictions” IEDB tool with default parameters of 1st, 2nd, and C-term amino acids; epitopes were ranked by total score combining proteasomal cleavage, TAP transport, and MHC scores combined. HTL epitopes were identified by the “MHC-II Binding Predictions” IEDB tool, which gives a percentile rank by combining 3 methods (viz. combinatorial library, SMM_align & Sturniolo, score comparison with random five million 15-mer peptides within SWISSPROT). B cell linear epitopes were identified by the “B Cell epitope Prediction” IEDB tool, which searches continuous epitopes based on propensity scales for each amino acid.

      From these proteins, 38 CTL top percentile ranked epitopes, 42 HTL top scorers, and 12 B cell top scorers were used for further analysis. Candidates were then analyzed for epitope conservation analysis (number of protein sequences containing that particular epitope), toxicity, population coverage, and overlap with one another. 9 epitopes that overlapped among all three types (CTL, HTL, and B cell linear) were then analyzed for interaction with HLA binders, showing stable binding with A*11:01, A*31:01, B3*01:01, and B1*09:01, and TAP, demonstrating ability to pass from cytoplasm into the ER. Two MEVs were formulated using the top CTL and HTL epitopes, which were then analyzed for physicochemical properties, allergenicity, and potential to induce IFN-gamma production. Final 3D modeling, refinement, and discontinuous B cell epitope analysis were completed to optimize the space-occupancy of the MEVs. This rendering was used to assess docking with TLR3, the major domain used by Ov-ASP-1. Codon adaptation optimization yielded cDNA capable of high expression in mammalian host cells. Taken together, this in-silico study produced two MEVs containing CTL, HTL, and B cell epitopes capable of eliciting potent cell-mediated and humoral responses for HLA types representing up to 96% (SD 31.17) of the population. Further in vitro study is warranted to confirm its clinical potential.

      Limitations:<br /> In silico approaches are based upon models, however accurate, that make certain assumptions and contain biases inherent to training data. Synthesizing and testing a few candidates alongside their initial findings would make this method far more robust. It remains to be seen the efficacy of screened epitopes and corresponding multi-epitope formulations function in vitro and in vivo models.

      Significance:<br /> This study reports an in silico approach to producing multi-epitope vaccines that can produce potent adaptive immune responses. Utilizing protein databases, established protein modeling, folding, and docking algorithms, as well as population analysis, the team identifies 38 MHCI-binding, 42 MHCII-binding, and 12 B cell epitopes that can be linked with Ov-ASP-1 adjuvant to form stable proteins. These proteins are shown to dock well with HLA-alleles, TAP, TLR3, and to induce IFN-gamma responses.

      Review by Matthew Lin as part of a project by students, postdocs and faculty at the Immunology Institute of the Icahn School of Medicine, Mount Sinai.

    1. On 2025-10-22 06:16:15, user KJ Flynn wrote:

      Interesting work .. two comments/suggestions for your consideration:

      For plankton, one of the major routes to establish whether something is critical is to have it described in a simulation and conduct a sensitivity analysis. The problem is that the sorts of details in this work never get into plankton models. This disparity between especially omics and models has been raised most recently by Flynn et al. (2025) https://doi.org/10.1038/s41559-025-02788-3 . It would be really helpful for you to flag how this work could usefully inform next generation plankton models.

      My second point concerns 'mixotroph'. From the tone of the discussion on this point, I assume you refer to photo-phagotrophy, as undertaken by mixoplankton. The problem with 'mixotroph' is that diatoms are strongly mixotrophic, via photo-osmotrophy (a trait well studied back in the 1960's etc. and exploited in algal biotech). I suggest that you consider using 'mixoplankton' to identify those organisms which are photo-phagotrophic. Checking organisms against the contents of the Mixoplankton Data Base of Mitra et al. (2023) https://doi.org/10.1111/jeu.12972 , may help as this catalogues trophic modes and many other features of these organisms.

    1. On 2019-08-06 16:03:30, user François Charih wrote:

      Very interesting paper indeed. The results are consistent not only with the new paper by Blacher et al., but also with an observed impact of nicotinamide riboside supplementation on ALS progression by de la Rubia et al., 2019.

      See Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):115-122. doi: 10.1080/21678421.2018.1536152.

    1. On 2021-04-29 16:28:33, user WebbsWonder wrote:

      Really nice! A suggestion for a change in title. "UBP12 and UB13 stabilize COP1 to promote CRY2 degredation". Current title suggests a complete revision of Ub model, but your conclusion makes clear that is not what you are suggesting. If I have understood it all properly!

    1. On 2016-02-10 17:03:00, user Jose Manuel Alonso wrote:

      Dear Matteo,

      Nice fits to our data. As you know, our original PNAS paper (1) already indicated that differences in luminance response linearity between ON and OFF pathways are likely to originate in the photoreceptor. This is stated in the abstract, significance statement, results and discussion of our paper. We support this interpretation with measures of responses from receptive field centers and surround in thalamus and with modeling (the equation that you use for your fits is identical to our equation 2 provided in the supplementary material).

      In our model (Equations in the supplement) adaptation was defined by c50(bg) and n(bg) of the Naka-Rushton function both being affected by the luminance level of the background. It is interesting that you get excellent fits to one of our data examples with changing one parameter of the Naka-Rushton function, but there is no direct evidence that our thalamic recordings reflect only photoreceptor adaptation (see Fig. 3E-H for population data). In fact there is evidence of subtractive adaptation to prolonged lights in ganglion cells (2), which would be reflected in thalamic cells. Just want to make sure that readers of bioRxiv do not get confused.

      All the best,

      Jose Manuel and Qasim

      1. Kremkow, J., J. Jin, S. J. Komban, Y. Wang, R. Lashgari, X. Li, M. Jansen, Q. Zaidi and J. M. Alonso (2014). Neuronal nonlinearity explains greater visual spatial resolution for darks than lights. PNAS 111(8): 3170-5.
      2. Zaidi Q, Ennis R, Cao D, Lee B. (2012). Neural locus of color afterimages. Current Biology. 7;22(3):220-4.
    1. On 2019-08-20 20:04:33, user Froylan Calderon de Anda wrote:

      Really nice pre-print. Unfortunately, some manuscripts related to one of the gene encoded in the 16p11.2 region are not properly listed in the introduction. TAOK2 has been shown to affect spine formation (Yasuda S, Neuron. 2007;56(3):456-71; Ultanir SK, Neuron. 2014;84(5):968-82; Yadav S, Neuron. 2017;93(2):379-93.), basal dendrites formation (de Anda FC, Nat Neurosci. 2012;15(7):1022-31), animal behaviour, and brain morphology (Richter M Mol. Psychiatry 2018).

    1. On 2023-08-11 09:19:40, user Bart Knols wrote:

      The reasoning (abstract) that 'However, sterilization by traditional methods renders males unfit, making the creation of precise genetic sterilization methods imperative.' is not correct. It is a justification for the type of research conducted here but does not do right to classical (radiation-based) SIT. See for instance the article by Bouyer and Vreysen (2020) titled 'Yes, irradiated sterile male mosquitoes can be competitive!' (Trends Parasitol., 36, 877-880). Our own research has shown the same, that doses of irradiation sufficiently high to induce satisfactory sterility in mosquitoes whist safeguarding their competitiveness is possible. Article upon article that focuses on gene drive or other gene engineering approaches uses 'lack of competitiveness' as a justification for moving away from classical SIT. This view stands to be corrected.

    1. On 2019-07-03 18:31:06, user Charles Warden wrote:

      1) A peer-reviewed version of this article is now available:

      https://bmcgenomics.biomedc...

      2) Since BMC Genomics doesn't have a Disqus comment system, I apologize for posting this here (although I hope this changes in the future).

      However, I noticed "HPV" was defined as an abbreviation in the peer-reviewed version, without being used in that version of the paper.

      In the pre-print, I do see some analysis of "72 TCGA HNSC tumor samples with valid Human Papillomavirus (HPV)," but it looks like they changed the comparison to tumor-versus-normal (while accidentally keeping the abbreviation in their draft).

    1. On 2018-06-27 02:31:06, user bgulko wrote:

      If anyone is considering covering this in a journal club or reading group and would like involvement or presentation support from an author, I'd be happy to participate. I'm presently in the San Francisco Bay area, please don't hesitate to contact me! --Brad Gulko

    1. On 2016-03-20 21:24:30, user James Wilson, M.D. wrote:

      I would be very cautious about the use of the word "pandemic". While Fauci et al have argued for a liberal definition of the term (i.e. NOT necessarily full penetrance of the infectious agent into the broader human population), it is a politically charged term. It is our perspective that overuse of this term may not be ethical, as it tends to play to political fear (and hence, funding) without providing a valid contextualization of the threat.

      You are going down the right path in contextualizing this as a tropical belt issue versus a pole-to-pole issue. Zika thus far is not showing any signs of autochthonous transmission in temperate regions.

      The overall backdrop is a decrease in credibility of the entire global public health enterprise, thanks to hyperbole and highly reactive response behavior. The precedence includes the translocation of West Nile to the western hemisphere, SARS, pandemic H1N1, MERS, translocation of CHIK, and of course, Ebola (to name a few). Providing balance to the assessments on Zika is of broader importance than that of a simple academic paper.

    1. On 2019-06-03 20:39:45, user Jon Moulton wrote:

      When discussing the disagreement between Morpholino and mutant phenotypes, the possibility of genetic compensation concealing the MMP9 loss-of-function phenotype is not raised (Didier Stainier has shown this to be a mechanism causing mutant-morphant phenotype differences).

    1. On 2016-06-16 00:47:59, user PornHelps wrote:

      "Sharing this manuscript with scientific community through bioRxiv"<br /> This is false. This is a public website, as you are aware.

      "Sexual Arousability Inventory (SAI)"<br /> Which is not a measure of sexual desire, so no, you did not control for it.

      "For majority of people it seems to be an entertainment."<br /> False, the overwhelming majority of use is for masturbation. People don't watch porn eating popcorn. If you didn't assess orgasm and masturbation separately, then any "effects" you document could actually just be due to masturbation anyway.

      How powered were you to detect those "not significant" effects in this little fMRI study?

      Why do exclude women, who actually respond just as strongly (neurally) to men to porn? Sexism in science much?

      Shall I keep going? Or would you remove this unethical post pre-publication? Should I check with the other authors directly to see if they actually consented to having their manuscript, un-reviewed, posted on a website accessible to the general public?

    1. On 2020-08-29 20:48:17, user Manfred Wuhrer wrote:

      Interesting to see that the recombinantly produced N protein is glycosylated. However, I doubt that the N protein of the intact virus is likewise glycosylated. I assume that the recombinant N protein is steered to the ER and Golgi explaining its glycosylation. For the N protein produced by the SARS-CoV2 infected cell I expect that it will not enter ER and Golgi but rather dwell in the cytosol upon translation and therefore may lack glycosylation.

    1. On 2020-12-14 15:23:10, user Ben wrote:

      @reporters<br /> Please read the abstract (or even just some tweets from scientists) before you write your report. The title is overstated and walked back immediately in the abstract. Please be mindful of your influence.

    1. On 2020-11-09 16:37:20, user anon wrote:

      Very surprising to see some of the most basic controls missing here. A simple "(LNF+mRNA) without exosomes" control is nowhere to be found, and all of the results shown can easily be due to treatment with liposomal mRNA on its own with exosomes spiked in. There's no evidence that the exosomes are helpful or do anything at all. The expression of the SARS-CoV-2 mRNA in cultured cells using patient sera is also unusual, as a Western blot from cell lysates with a monoclonal antibody would give more information, including confirmation that the full-length antigen is expressed.

      I guess this is a pre-print, but some of the basic experimental design, materials/methods, and controls leave quite a few open questions.

    1. On 2015-07-13 12:08:42, user Celia Rodrigues wrote:

      If the author wanted to make a point, the example chosen of the DNA helix by Watson and Crick was the worst one. It just shows how you can easily steal the work of someone else and publish it quickly. It is not even a proper scoop as they didn't have any raw data. Imagine all the reviewers of this world getting a really good manuscript with an original idea that will change the world and they quickly publish their "bold" idea without any data and get all the credit before the group with the raw data and paper almost ready to publish. I agree that some flexibility could exist and that maybe this isn't the perfect system, but your example poorly illustrates your point. It even makes me doubt anything is said in the text after that.

    1. On 2018-04-20 13:24:10, user Neil Kad wrote:

      This is a really beautiful piece of work that highlights the importance of the region around residue 50 in forming the protofilament interface. <br /> Interestingly, in 2015 we previously showed that this region was important in amyloid fibril formation by using an in vivo semi-rational peptide selection method. In our paper we created a peptide based on the 45-54 region of a-syn that actually inhibited fibril formation.

      The paper is here: https://dx.doi.org/10.1074%...

      I think it would be a useful addition to the discussion since it is very pertinent to your conclusions.

    1. On 2017-08-24 09:49:57, user Wouter De Coster wrote:

      Dear authors,

      This is great work and I'm eager to try this method after my holidays. It is essential that the community explores the possibilities of improving on existing tools and pushes the field forward and this is a nice contribution.

      I think the preprint is well written and I have a few minor comments/suggestions:<br /> Abstract:<br /> - "Here, we report the first deep learning model - Chiron - that can directly translate the raw signal to DNA sequence, without the error-prone segmentation step."<br /> If I'm not mistaken Albacore is also moving away from event detection/segmentation, see also https://community.nanoporet... The same argument returns later in your manuscript. Now you are probably correct, but if you consider submitting this to a journal and going through peer review I think Albacore might be using raw data by then. The plans to move away from segmentation have been around for a while, but Chiron is still the first to implement it in practice.

      Introduction:<br /> - "The device then uses the signal to determine the nucleotide sequence of the DNA strand"<br /> => It is a minor detail, but basecalling is not performed on the device itself.

      Comparison with existing basecallers:<br /> I read on twitter that you are also retraining on human data. It is apparent from Table 1 that all tools perform worse on human data, so I think this is definitely an application in which improvements are very relevant and will likely make a big impact. Perhaps you can comment on why the basecallers perform less on the human data? The accuracy of Chiron is impressive given the fairly limited training dataset you employed for this analysis.

      Areas left undiscussed are nucleotide modifications and basecalling of direct RNA, which would be worth exploring I guess and potentially have an important impact.

      A typo:<br /> -Albacore is considered the ’gold standard’ in terms of accuracy, but as it is not open source, we cannot comment on **it’s** implementation.<br /> => its implementation

      Cheers, <br /> Wouter

    1. On 2017-12-05 13:38:00, user James Lloyd wrote:

      Very interest results from an elegant set of experiments, thank you for posting to a pre-print server.

      The only comment to try and improve the paper slightly is that I think some more explicit focus on the overlap of differentially expressed genes and regions with gains/losses in repressive chromatin. For example, does expansion of heterochromatin in XO males lead to repression of any of these newly marked genes, as one might expect from previous work on changes in PEV? I get the impression from the work that this effect is modest or nonexistent, and most of the expression changes are linked to sex determination (a very interesting result), but I think some more explicit focus on this would be really useful for the reader.

    1. On 2019-10-21 00:55:10, user Jean-Michel Ané wrote:

      A 20% decrease in Hartig net boundary to root circumference when CASTOR/POLLUX or CCaMK are knocked-down is not what I call "a very subtle decrease in ectomycorrhizae". See Figure 10D of Cope et al. (2019) http://www.plantcell.org/co....<br /> I totally agree that CASTOR/POLLUX and CCaMK are obviously dispensable for some ecto-mycorrhizal associations but, at least in the case of Populus, @KevinCope18 has demonstrated that they play a significant role in this association.

    1. On 2018-10-11 14:05:32, user Luigi Antelmi wrote:

      Thanks for sharing this idea!<br /> Question 1: Why you use the log-likelihood to compare the models and not the ELBO, that should be a proxy to the data evidence?<br /> Q2: How do you compute the KL term in the non-gaussian prior cases?<br /> Q3: Are you willing to publicly share your code?<br /> Thanks for any answer you can give!

    1. On 2023-04-13 15:40:20, user ENK wrote:

      1). There is a typo on page 11, I think. "as clusters associated with cell types and/or organ formed grouped when TF family members were clustered phylogenetically"

      2) Fig 2C is missing an explanation/label for the shading gradient variable.

      3). For figs 6A and 6B, you do not indicate what cluster 6 is. I would also encourage the authors to put the cluster identities in the figure itself or in the figure description, not just in the body of the text.

      Generally, I would encourage the authors to go over the figures again with consideration with ease of audience interpretability in mind.

    1. On 2020-09-21 08:18:32, user Jouke- Jan Hottenga wrote:

      See this: Am J Hum Genet. 2000 Jan; 66(1): 279–292. PMID: 10631157<br /> A General Test of Association for Quantitative Traits in Nuclear<br /> Families.

      Interested in the comparisons between the TDT, classic linkage sib-pair analyses and these methods, because all are a different take on - but converge to - the same principle of explaining variation in human traits.

    1. On 2018-05-15 07:05:45, user Hannah Gruner wrote:

      Fascinating work!

      I’m intrigued what signaling pathway Ddx3x is important for given the lack of change in canonical Wnt signaling. I’d be curious if non-canonical Wnt signaling may be involved considering the PCP pathways role in cortical neuron maturation (PMID:26939553; 19332887).

      The intermediate progenitor increase in the Ddx3x LOF reminds me of a similar phenotype observed Slit1/2 and Robo1/2 mutant animals (PMID:23083737). As Slit-Robo signaling is associated with intellectual disabilities (PMID:12195014), and Slit2 and Robo1 are highly enriched in the Oh, et al. 2015 iCLIP data, it would be interesting to see if this signaling pathway is affected in Ddx3x knockdown as well.

    1. On 2021-09-05 14:38:51, user Rodrigo Lorenzi wrote:

      I just took a look at the article. My question is: what happens when someone vaccinated is infected by a variant. Do they produce new antibodies against this variant or the only antibodies at work are those induced by the vaccine?

    1. On 2024-12-23 05:56:36, user David Lloyd wrote:

      Dear Joel and Brokoslaw,

      I read with interest your preprint and it seems like a nice piece of work based on well established methods. However, I do encourage you to please cite the original research and papers that led to your current implementation. For example, your equations 1 and 2 and wording for Neural Activation Model seem directly taken from Lloyd and Besier J Biomech 2003 equations 1 and 2, and Buchanan et al J Appl Biomech, 2004, equations 3-7 and 12. The concept to add this Hill Type muscle model muscle force dynamics also stems from this 2003/2004 work, although your work does not include tendon models. This work by myself and long line of PhD students and research fellows across many different laboratories around the world, has also been led to the development of using these model for real-time applications (e.g., Pizzolato et al, IEEE TNSRE, 2017; Durandau et al, <br /> IEEE TBME, 2017) real-time control of exoskeletons (e.g, Durandau et al, IEEE T-RO, 2022; Durandau et al, JNER, 2019), and function electrical stimulation. (e.g., Hambly et al, IEEE ICORR, 2023). Again I encourage you to cite the original research papers and not make claims like "we developed a new EMG-to-activation model" and "Our new EMG-to-activation model begins with activation dynamics..." Nevertheless, I encourage you to continue this line of research, especially the impedance control.

      Kind Regards

      David Lloyd

    1. On 2019-02-26 18:08:53, user Cory Sheffield wrote:

      Did you look for differences between males and females for each species? Not only are males typically smaller, but emerge faster (i.e., from eggs which are laid last in the tunnel), which seemingly would support your trend. But this occurs in both late emerging species (i.e., those wintering as mature larvae) which have more variation in emergence time, and in those early spring emerging species with narrow emergence times. So, is the early emergence of males only because they are smaller, or is there something else involved? What about larger males?

      Also, did you look for differences in body size based on the size of nesting tunnel the occupants were in? Tunnel diameter will influence body size, so it would appear that when a species nests in a smaller diameter tunnel, it will emerge faster than a conspecific from a larger tunnel. Was this the case?

      Why not look to see if the pattern is supported within a taxon (ie Megachile). Megachile inermis is are largest native Megachile species in Canada that uses trap nests, but you have several smaller species that emerge later in your figure. Thus, how do you know the variation is not due to something other than body size? Perhaps timing of emergence is based on synchrony with floral hosts for species with more dietary restrictions, or for parasitic taxa whose emergence times are typically later than their hosts? Could food quality influence emergence time? Are cleptos larger than their hosts to emerge later?

    1. On 2020-08-13 08:23:35, user Martin R. Smith wrote:

      This is an interesting study and a promising approach. <br /> My one question would be whether the Robinson-Foulds distance is the most suitable measure of tree distance on which to base the linkage ratio. The RF distance suffers from a number of shortcomings, many of which are exacerbated when pectinate (i.e. fully unbalanced) trees are involved, as moves of a single leaf can 'knock out' a disproportionately large number of splits – so it might have particular scope to produce misleading results in the examples that you have used.<br /> I've reviewed some possible alternatives in Smith (2020), Bioinformatics, doi:10.1093/bioinformatics/btaa614 , and fast implementations are available in my R package 'TreeDist' – though unfortunately I don't yet have a python front end to the underlying C++ code. The quartet distance might be particularly relevant, as the distance between two entirely random trees takes a constant value (1/3) – would this obviate the need to generate unliked topologies in order to normalize the linkage ratio?

    1. On 2016-05-21 01:38:57, user Jim Hofmann wrote:

      Shouldn't this be "unexplored"?:<br /> "Until recently model selection remains an explored topic and the impacts of using different models on inferring biogeographic history are poorly understood."

    1. On 2023-03-02 22:22:51, user Evan Saitta wrote:

      Congratulations on the study! It is very interesting and plays an important role in collating this useful data!

      I have explored sexual dimorphism, including in body mass, in extinct organisms (https://academic.oup.com/bi... "https://academic.oup.com/biolinnean/article/131/2/231/5897459)"). I am jealous of your extant research subjects!

      If you are looking for feedback on your preprint, then I am happy to give my thoughts (for whatever those are worth).

      I think your second figure is a more apt portrayal of the data than your first, because it presents the data with a mind towards effect size statistics (i.e., it reports the estimated magnitude of dimorphism and the uncertainty in that estimate without additional interpretation).

      Namely, I think that the secondary methodological step of designating each species into a categorization of dimorphic or monomorphic might obscure the excellent data you have amassed.

      I certainly understand and appreciate your use of objective criteria to assign a monomorphic label (i.e., when the 95% confidence interval straddles zero in estimated dimorphism magnitude). However, any finite population of males and females is not expected to have an effect size of precisely zero, even if just for stochastic reasons rather than reasons of sexual selection (or lack thereof!).

      So, what does the "same size" category actually include then?

      Those species that are labelled as "same size" between males and females could be those with relatively modest magnitudes of dimorphism (i.e., near, but not exactly, zero) and/or those with small sample sizes and therefore higher uncertainty (i.e., larger confidence intervals).

      For example, if you assume that these 39% of species that fall into the "same size" category are roughly equally likely to sit either just barely above or below zero effect size, then that would mean about 63.5% of species in orders with 10 or more taxa have an estimated effect size that places average male size greater than average female size -- albeit that many of those species have modest dimorphism and/or high uncertainty.

      That would seem (to me at least) to differ from the conclusion that males are not larger than females in most mammals, which I assume is derived from the "larger males" category being less than 50%, at 44%.

      I applaud your use of effect sizes and confidence intervals! However, I worry that by using these confidence intervals to then make a dichotomous (or trichotomous?) categorization, the method then becomes prone to the same shortcomings as does binary significance testing based on p-values (an approach that is becoming more and more criticized: https://www.nature.com/arti... "https://www.nature.com/articles/d41586-019-00857-9)").

      Of course... I could be wrong!

      Did I understand your work correctly? Do my comments make sense? Am I totally mistaken about something here?

      PS. I was Princeton EEB undergraduate class of 2014 (Advisor: Gould) and will be attending reunions this year. Perhaps we can meet up at some point to discuss your fascinating work, and maybe you can give me some advice about how to deal with these pesky fossils!

      Go Tigers!<br /> Evan Saitta

    1. On 2023-03-19 19:02:36, user Clay McCann wrote:

      Not quite clear here on what constitutes "poisoning" when the LD-50 for cannabis remains unknown, when cannabis is one of the least toxic substances known to humanity, and especially when humans have no CB receptors in the brain stem (making it literally impossible to overdose on cannabis). This "study" represents more than half of all cannabis research, instrumentalized as drug scare propaganda.

    1. On 2025-04-15 13:14:47, user Donald R. Forsdyke wrote:

      THE "ACCENT" OF DNA

      You can explain the "de-extinction" problem, be it with mice or dire wolf, historically by considering the four bases in DNA sequences:

      1. Chargaff circa 1950 discovered that DNA base composition (not sequence) was a species characteristic, simply expressed as GC% (as opposed to AT%).

      2. So, there were GC%-rich species and AT%-rich species, with the exact values differing between species.

      3. We biochemists and others discovered circa 1990 that actually the difference was due to short sequences (k-mers).

      4. Thus, for k=3. GC%-rich species would be enriched in GTC, GGA, GGC, CAG, etc. Whereas for an AT-rich species ACT, AAG, AAT, TGA, etc.

      5. Given 4 bases (A, C, G, T), for k=2 there would be 4x4 = 16 possibilities. For k=3 there would be 4x4x4 = 64 possibilities.

      6. In practice the range varies from k=3 to k=8.

      7. Fragments of DNA from, say, a soil sample, will correspond to a variety of species in the sample. But just by assessing the k-mer patterns in the fragments, those corresponding to each species can be identified.

      8. Then you can look at the fragments corresponding to one species and examine long sections to identify gene sequences (viewed as "sentences" or "word strings").

      9. So, k-mers can be seen as the "accent" or "dialect" of DNA that relates to what species it belongs to. Unless you take that into account you cannot make a new species by just inserting a few genes to change appearance.

      10. Just as accent can influence reproductive choices between humans (remember Eliza Doolittle), so it influences the reproductive isolation that is the defining characteristic of a species.

      [A paper in the December 2024 issue of the Journal of Theoretical Biology goes into more details. Or see my textbook - Evolutionary Bioinformatics (3rd edition, 2016).]

    1. On 2019-10-09 20:54:16, user Yibing Shan wrote:

      The stated 120 Å receptor-receptor separation by the crystal FERM dimer model was a mistake. The concern about that model may have to do with the position of K279 of EpoR, which is only 5-residue away from the transmembrane helix but some 20 Å away from the membrane.

    1. On 2022-08-13 17:57:32, user Rajender Singh wrote:

      Dear Authors, <br /> Lopez et al. is not the right reference as you have stated in your manuscript in the line 'The sequences in the nuclear genome with mitochondrial origins are called numts and their integration process itself is called numtogenesis (Lopez et al., 1994).'

      You should replace this with other suitable references, which I am mentioning here;

      Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma. PMID: 28356157

      Single molecule mtDNA fiber FISH for analyzing numtogenesis. PMID: 28322800

      Numtogenesis as a mechanism for development of cancer. PMID: 28511886

      I hope you will take a note of my comment.

      Thanks.

      Dr. Rajender Singh<br /> Senior Principal Scientist and Professor

    1. On 2016-09-23 09:20:17, user Javier Forment wrote:

      Nice and useful work! Thanks! Maybe I'm wrong, but I didn't find in the manuscript how can I start my own Jupyter notebook inside Galaxy, other than making a copy of yours one and editing it.

    1. On 2016-10-10 23:47:19, user Anshul Kundaje wrote:

      Very nice paper. A few questions and clarifications.

      1. Whats the negative set you used in the TFBS prediction evaluation (supp. fig 2). Its not clear from reading the methods.
      2. Also was evaluation of each method done on held out chromosomes for that specific method i.e. chromosomes not used in training? E.g. DeepSEA holds out chr8 and 9 and trains on data from all other chromosomes for all data types across a range of cell types. So if you are evaluating performance of DeepSEA on sites in the training chromosomes, its not going to reflect test performance but rather training performance. Same goes for all other methods, unless you retrained them on all common training/test settings.
      3. Also please avoid reporting auROCs for TFBS prediction evaluation or for that matter any unbalanced prediction problem on the genome. They can be very misleading. auROCs of >0.9 can translate to terrible auPRCs (< 0.2) and very poor recall at reasonable FDRs (e.g. < 1% recall at 50% FDR). Could you please report auPRCs and recall at reasonable FDR thresholds?
    1. On 2022-11-15 15:46:13, user Leonid Sazanov wrote:

      From Prof. Leonid Sazanov, IST Austria.

      This preprint describes the first structures of mitochondrial complex I from Drosophila melanogaster (Dm). The work is done carefully technically and is a valuable addition to the current set of complex I structures from various species, previously lacking representatives from insects or Protostomia clade in general. Complex I from Protostomia, in contrast to that Deuterostomia including mammals, appears to lack so-called “deactive” state, which is important for mechanistic discussion. In this study authors find that apo (i.e. in the absence of any substrates or turnover) Dm complex I (DmCI) can adopt two main conformations, resembling so-called “open” and “closed” states seen previously with other species. Uniquely, one of DmCI states is characterized by the ordered N-terminal helix of the accessory NDUFS4 (18 kDa) subunit, which wedges between the peripheral (PA) and membrane (MA) arms. This was not seen in other structures and appears to be a specific feature of Dm and closely related species. Authors suggest that the helix may temporarily “lock” this DmCI conformation. However, it may instead just reflect the ordering of a particular structural element in one of complex I states, as seen for different parts of complex I in other species.

      Overall, the new DmCI structures are consistent with our recent mechanistic proposals [1, 2] and complement the emerging picture. However, the discussion of the two states in this work is very confusing in my opinion, which is why I wrote this comment.

      It is surprising that the DmCI states were labelled as they were (locked open and closed) while it is clear that it should be other way round (locked closed and open). DmCI states were assigned by authors on the basis of PA-MA angle if complex I is viewed sideways, as we did for ovine complex I originally [1, 3]. In what authors called here the closed state this angle is very slightly smaller than in the other state, thus the assignment. However, it is clear from Fig. 4- suppl. 2A and movies that the main difference between the DmCI states is the rotation of PA, not the closing/opening of PA-MA angle.

      As we noted in our latest paper [2], the PA-MA angle is not a good indication of open or closed state – PA tilts in Ovine but mainly twists/rotates in E. coli. In E. coli the states are related by PA clockwise rotation (when looked from PA tip) when going from closed to open state. In the recent paper on Chaetonium complex I [4] – form 1 is clearly open state, form 2 is clearly closed (in our updated nomenclature as below). They are related by the PA clockwise rotation (when looked from PA tip) going closed-to-open (2-to-1). I.e. it is the same overall change as in E. coli. ??

      Therefore open and closed states should be attributed not by PA-MA angle, as we noted [2], but on the basis of:<br /> ?Open state - OPEN Q cavity (mostly disordered key loops, especially ND3) and pi-bulge in ND6 (as well as flipped out into lipid ND1 Y156 in E. coli / Y142 ovine).<br /> ?Closed state – CLOSED Q cavity (mostly ordered key loops, especially ND3), no pi-bulge in ND6 (as well as flipped in into E-channel ND1 Y156 in E. coli / Y142 ovine).

      ?So what was called locked open state in DmCI in fact clearly corresponds to closed state in our nomenclature (ND3 loop ordered, no pi-bulge). What was called closed state in DmCI is in fact open state (ND3 loop disordered, pi-bulge present). The only difference with E. coli open state is that NuoC beta1-2 loop is retracted in DmCI but is inserted into Q cavity in E. coli (incidentally, some of labels describing E. coli features are wrong in Fig.5-suppl1BC). However, in Ovine this loop is disordered in open state, so its conformation is not absolutely defined by the state (unlike ND3 loop and pi-bulge). Another difference is that in DmCI open state PSST loop is not flipped as in Ovine. However, in E. coli this loop does not flip either, so again its conformation is not absolutely defined by the state. Considering the re-assignment of states as we suggest then the PA rotation going closed-to-open is in the same direction in DmCI as in E. coli. A similar rotation was also noted in another recent manuscript on DmCI [5].

      In summary, after re-assignment it is clear that main features defining closed and open states (in our nomenclature) in DmCI are the same as in Ovine, E. coli and Chaetonium. It is possible that under turnover conditions in Drosophila even more of the features will become consistent (such as NuoC beta1-2 loop insertion in open state), however the assignment is already unambiguous. ??

      So to avoid confusing readers about what is open and what is closed state it would be great if authors renamed the classes according to our latest nomenclature as above.

      ?One potential question is that in parallel paper [5] (otherwise mostly consistent with this study) in Dm2 state (open state in our nomenclature) ND3 loop apparently remains ordered. However, Agip et al. did only global 3D classification on the entire complex I molecule which, according to our experience, is unlikely to fully separate classes - then any Dm1 (closed) state particles still present in Dm2 class would easily show ND3 loop density – we have seen this a lot when classification in not converged. Additionally, the resolution of Dm2 class is quite low.??

      Considering authors comment here on the poor density of some regions in our Ovine deactive structures, I need to note that these data were post-processed with high B-factor suitable for the main bulk density. ND5-HL, TMH16ND5, NDUFA11 are indeed not well defined but are still present as we can re-activate this prep. However, if one applies blurring B-factor of about 100 in COOT (or filter maps to about 4A) to the deposited densities of deactive states, then except for open1, all other states (especially open3 and open4) show very clearly relocated ND6 TM4 density together with loop blocking PA/MA movements. It is clear that after full deactivation ND5-HL, TMH16ND5, NDUFA11 become flexible but still associated with complex, while ND6 TM4 together with its loop relocates. <br /> ?<br /> Authors also mention in discussion that in Yarrowia both open and closed states were observed. However, as we discussed in the SI of our paper [2], only one conformational state was observed under turnover conditions in Yarrowia. It resembles the open state of Ovine CI – pi-bulge present, ND3 loop disordered, etc. The reported conformational changes in Yarrowia CI [6] may in fact reflect the deactive to open state transition, and the closed state remains to be properly classified out.??

      It is also a bit strange for authors to criticize our E. coli paper [2] on the basis on Kolata/Efremov paper [7] – we have clearly shown that the resting E. coli state is promoted by DDM detergent (which was used in [7]) and this is why we took a lot of care to fully purify enzyme in milder LMNG detergent, with clear data showing it is stable in LMNG. Further, air-to-water interface argument from authors is not applicable to our data – grids were made with continuous carbon layer support, so protein is never exposed to air during blotting/freezing. <br /> ?<br /> Authors also state that “thermophilic yeast Chaetonium thermophilum CI, which is found in multiple resting states, none of which corresponding to the open state seen in other species” [4] However, Chaetonium two states correspond very closely to Ovine open and closed states, as authors themselves state in [4]. So the point of the statement above is not clear.

      It seems like in the discussion the authors try hard to suggest alternatives to our mechanism, even though there are no real factual arguments here. One particular argument is that open states of complex I could be all deactive (as still suggested for mammals [5]) and do not participate in the catalytic cycle, with only closed state being part of catalytic cycle. However, all the new emerging data from species which do not have deactive state, i.e. E. coli [2], Chaetonium [4] and even including current Drosophila structures point out that closed-to-open transitions as part of catalytic cycle are universal.

      Overall, I hope that the discrepancies above will be corrected in the final paper.

      References

      1. Kampjut, D. and L.A. Sazanov, The coupling mechanism of mammalian respiratory complex I. Science, 2020. 370(6516).
      2. Kravchuk, V., et al., A universal coupling mechanism of respiratory complex I. Nature, 2022. 609(7928): p. 808-814.
      3. Fiedorczuk, K., et al., Atomic structure of the entire mammalian mitochondrial complex I. Nature, 2016. 538(7625): p. 406-410.
      4. Laube, E., et al., Conformational changes in mitochondrial complex I from the thermophilic eukaryote Chaetomium thermophilum. bioRxiv, 2022: p. 2022.05.13.491814.
      5. Agip, A.-N.A., et al., Cryo-EM structures of mitochondrial respiratory complex I from Drosophila melanogaster. bioRxiv, 2022: p. 2022.11.01.514700.
      6. Parey, K., et al., High-resolution structure and dynamics of mitochondrial complex I-Insights into the proton pumping mechanism. Sci Adv, 2021. 7(46): p. eabj3221.
      7. Kolata, P. and R.G. Efremov, Structure of Escherichia coli respiratory complex I reconstituted into lipid nanodiscs reveals an uncoupled conformation. Elife, 2021. 10.
    1. On 2021-09-12 02:24:50, user Raghu Parthasarathy wrote:

      Interesting paper! If you're going to claim a power law (such as an inverse square), however, it would be good to see the data plotted on a log-log scale, so that the scaling exponent is obvious, and also to see a robust fitting of the exponent value. Also, I don't see that the datapoints are available to the reader -- is there a supplemental data link missing? Thanks!

    1. On 2024-01-19 04:01:11, user Pamela Bjorkman wrote:

      This paper was published as: Barnes, CO, Jette, CA, Abernathy, ME, Dam, K-M A, Esswein, SR, Gristick, HB, Malyutin, AG, Sharaf, NG, Huey-Tubman, KE, Lee, YE, Robbiani, DF, Nussenzweig, MC, West, AP, Bjorkman, PJ (2020) SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588: 682-687. PMCID PMC8092461 doi:10.1038/s41586-020-2852-1

    1. On 2016-05-27 20:40:01, user Marcey Kliparchuk wrote:

      Chris Portier former Head of the National Toxicology Program stated, “ this is the best designed animal study every conducted on this topic.” Ron Melnick, who led the NTP study design team, confirmed these leaked results to Microwave News stating, “The experiment has been done and, after extensive reviews, the consensus is that there was a carcinogenic effect.”

      In 2011, the International Agency for Research on Cancer (IARC), a committee of the WHO, classified RF radiation as a Group 2B carcinogen in the same category as lead and DDT. Alarmingly, several scientists who were members of the IARC working group involved with this classification now conclude the risks are much greater than originally thought. For example, Dr. Dariusz Leszczynski warns that RF-EMF should be classified as a Group 2A carcinogen, and Dr. Lennart Hardell reports that several studies indicate a Group 1 classification is justified, placing RF-EMF in the same category as tobacco, asbestos, and benzene.

      For example, Dr. Dariusz Leszczynski MSc, DSc, PhD states “In conclusion, I consider that currently the scientific evidence is sufficient to classify cell phone radiation as a probable human carcinogen – 2A category in IARC scale. Time will show whether ‘the probable’ will change into ‘the certain’. However, it will take tens of years before issue is really resolved. In the mean time we should implement the Precautionary Principle. There is a serious reason for doing so.”

      Dr. Lennart Hardell “Based on the Hill criteria, glioma and acoustic neuroma should be considered to be caused by RF-EMF emissions from wireless phones and regarded as carcinogenic to humans, classifying it as group 1 according to the IARC classification. Current guidelines for exposure need to be urgently revised.”

    1. On 2019-08-08 09:06:22, user Rosalind Arden wrote:

      Keen to read this interesting study. It would make easier reading if the acronyms were cut out. They impose a cognitive load on everyone but the Authors (who are 'cursed with knowledge'!)

    1. On 2019-10-02 11:47:37, user Danielle Kurtin wrote:

      Hello,<br /> Thank you for preprinting this paper; it's been useful in the literature review I'm conducting for the start of my PhD. <br /> I noticed a few types in the manuscript. For example, the first sentence of the introduction begins as "Despite most neuroimaging studies still tend to treat human brain features as stable and homogeneous characteristics within a group, it is important to highlight that, in contrast, individual variability may play a relevant role in this context [1] [2]." Perhaps the following may be more correct: "Most neuroimaging studies tend to treat human brain features as stable and homogeneous group characteristics; however, it is important to highlight that individual variability may play a relevant role in this context [1] [2]."<br /> Let me know what you think, and thank you again!<br /> Cheers,<br /> Danielle

    1. On 2023-08-30 08:41:17, user Jose E Perez-Ortin wrote:

      This new model for explaining mRNA<br /> buffering is a very interesting piece of work. We would like to suggest some<br /> possible improvements to be considered by the authors in this preprint stage before<br /> it becomes published in a journal.

      In some parts of the manuscript it is said<br /> that mRNA buffering is perfect as total mRNA concentration and even individual<br /> mRNA concentrations are invariant. We think that this is overblown. For<br /> instance, graphs in Sun et al 2013 (ref. #9; Figure 1),<br /> the variability in total mRNA may be as high as 50%. In fact, in García-Martínez et al 2004 (ref. #15;<br /> Figure 2) we published that during the carbon source change mRNA concentration<br /> changes also by a factor of 2. We wonder if this could be important for the modeling<br /> because it seems that on the advantages of the RS model is that it predicts<br /> robust buffering, contrarily to previous feedback models.

      The manuscript misses citation of some<br /> papers that we consider important for the field of mRNA buffering, such as Mena et al 2017 (doi:<br /> 10.1093/nar/gkx974). This paper is especially relevant because the current<br /> preprint describes in the Introduction section that total mRNA concentration is<br /> constant as the cell volume increases (refs. 19-22) but forgets to mention this<br /> piece of work, which was the first one to show that degradation rate perfectly<br /> balances production rate during cell volume change. Instead of our paper, the<br /> preprint cites ref. #27, which is 4 years older than Mena et al 2017.

      Garcia-Martinez et al<br /> 2023 (doi: 10.1016/j.bbagrm.2023.194910) is also highly relevant. We described in that<br /> article a mathematical model that explains mRNA buffering using a simpler<br /> mechanism consisting only one mRNA binding factor that co-transcriptionally imprints<br /> mRNAs. That model also predicts that synergistic changes in synthesis and<br /> degradation rates will provoke faster and stronger responses, as described in<br /> some experiments. We also previously published a multiagent model in Begley et al 2019 (10.1093/nar/gkz660),<br /> which combines mRNA imprinting and feedback mechanisms. That paper also<br /> demonstrates that Ccr4 and Xrn1 act in parallel with different sets of targets<br /> genes. We also have demonstrated in that paper and in other two (Begley et al 2021 doi:<br /> 10.1080/15476286.2020.1845504; and Medina et al 2014 doi:<br /> 10.3389/fgene.2014.00001) that protein factors, such as Ccr4 and Xrn1 act not<br /> only in transcription initiation level but also in elongation . We think it<br /> would be nice this manuscript to discuss the differences of these models with<br /> the proposed RS model.

      Finally, as for the model in Figure 4c, we do not understand why the<br /> activation of a degron used by Chappleboim et al 2022 (ref. #16) only<br /> degrades cytoplasmic Xrn1 molecules (Xc) and leaves Xp molecules intact. All<br /> Xrn1-degron molecules (Xc, Xp, Xn) will be proteolyzed after Auxin addition.<br /> This can affect the predictions made by the RS model.

    1. On 2021-11-06 20:07:56, user Binks Wattenberg wrote:

      We find this to be a very exciting and compelling study that establishes that the turnover of the ORMDL proteins is regulated by sphingosine-1-phosphate signaling in vascular endothelial cells. We do, however, have a different model as to the role of this system as a homeostatic mechanism controlling sphingolipid biosynthesis.

      We consider the ORMDLs to be regulatory subunits of SPT which, like many regulatory subunits, are not intrinsically inhibitory until they are triggered by a ligand. Our evidence strongly indicates that the ligand for the SPT/ORMDL complex is ceramide. With this in mind, we envision that the S1P regulation of ORMDL stability overlays an acute and direct ORMDL-dependent regulation of SPT by ceramide. In our view, the S1P-dependent stabilization of the ORMDLs maintains them as ceramide-sensitive regulators of SPT. In the absence of S1P signaling, degradation of the ORMDLs renders the SPT complex insensitive to ceramide and therefore strongly increases SPT activity.

      Below we outline evidence which brings us to this view. But before doing so, we would like to emphasize one of the exciting and important aspects of the work outlined in this pre-print. Considering that S1P signaling is mediated by the G-protein linked S1P receptors (in this case S1PR1), it is an interesting possibility that other cell types with different requirements for control of sphingolipid biosynthesis will utilize the same downstream signaling, perhaps mediated by other G-protein receptors, to control ORMDL levels. A hint of this is found in the regulation of ORMDL turnover by cholesterol loading reported by Gulshan and colleagues (Autophagy. 2015;11(7):1207-8).

      The experiments that underlie our view of that the enzymatic activity of the SPT/ORMDL complex is directly responsive to ceramide levels is as follows. It is important to emphasize that the bulk of these studies were performed in Hela cells. The biochemistry of the SPT/ORMDL complex itself is likely independent of cell type, but additional regulatory mechanisms, such as those presented in this pre-print, are doubtless cell-type dependent:

      1. Sphingoid bases do not mediate an acute ORMDL-dependent regulation of SPT. We tested the identity of the sphingolipid that triggers ORMDL inhibition of SPT by feeding Hela cells sphingosine. This results in an almost complete inhibition of SPT. This is consistent with the sphingosine inhibition of SPT activity in intact cells originally reported by Kondrad Sandhoff’s group (Mandon EC, van Echten G, Birk R, Schmidt RR, Sandhoff K.Eur J Biochem. 1991 Jun 15;198(3):667-74). This inhibition is entirely ORMDL-dependent. Importantly, we demonstrated that sphingosine inhibition of SPT was completely blocked by preventing ceramide generation with the ceramide synthase inhibitor Fumonisin B1 (Figure 2 of J Biol Chem. 2012 Nov 23;287(48):40198-204 and Figure 2 of J Biol Chem. 2019 Mar 29;294(13):5146-5156. ). Thus, inhibition by sphingosine requires its conversion to ceramide. S1P generation, enhanced by sphingosine feeding, is not blocked by Fumonisin B1, yet SPT inhibition is ablated. Therefore, in this system, S1P does not appear to have a role in regulating SPT activity in Hela cells under the short-term conditions that we used. We concluded from these experiments that the triggering sphingolipid is ceramide or a complex sphingolipid such as sphingomyelin or a glycosphingolipid, but not a sphingoid base.

      2. Elevation of ORMDL levels alone does not lead to SPT inhibition. We have shown that inhibition of SPT by ceramide In Hela cells and human bronchial epithelial cells (HBEC) cannot be explained by increased ORMDL protein expression. We do not observe an increase in ORMDL protein expression in response to C6-ceramide treatment of Hela Cells (Figure 5, Siow et al 2015), under conditions in which SPT activity is strongly inhibited. And we demonstrate that ectopically increasing ORMDL protein expression in either Hela cells or HBEC does not result in inhibition of SPT activity (J Lipid Res. 2015 Apr;56(4):898-908). In both of these cells there is sufficient ORMDL at steady state to serve the needs of SPT regulation, yet ceramide is strongly inhibitory. We make the point in this paper that the stoichiometry of ORMDL to SPT expression is important and make clear that it is likely that in some cell types changes in ORMDL expression will impact on SPT regulation. This is consistent with the response reported in this pre-print in response to S1P signaling.

      3. Biochemical reconstitution demonstrates a direct inhibitory effect of ceramide. We have reconstituted ceramide-triggered, ORMDL-dependent inhibition of SPT in isolated membranes in a biochemical assay in which neither protein synthesis, turnover, nor post-translational modifications can occur. We are confident that this biochemical reconstitution reflects a physiological response of the SPT/ORMDL complex to ceramide. We demonstrated that the response to ceramide is strictly stereospecific with respect to ceramide stereoisomers. Only the native, D-erythro ceramide stereoisomer triggers ORMDL-dependent inhibition of SPT. Moreover, we addressed the possibility that the short-chain ceramides that we routinely use (for their solubility properties) might not reflect physiological inhibition. We generated native chain-length ceramide in the isolated membranes using the endogenous ceramide synthases. This ceramide was strongly inhibitory (Figure 2 of J Biol Chem. 2019 Mar 29;294(13):5146-5156).

      4. The recently published structures of SPT/ORMDL complexes reinforces the view of the ORMDLs as regulatory subunits. The ORMDLs are firmly embedded in the structure. Moreover, comparison of the structures in the substrate-free and substrate-bound state indicates that the ORMDLs inhibit SPT via an amino-terminal sequence that reversibly inhabits the substrate binding site of SPT. These structures suggest that the inhibitory sequence must be stabilized in the active site of the protein to achieve inhibition. We propose that ceramide binding to the complex accomplishes this stabilization.

      Taken together, our data and that presented in this pre-print form the picture that the ORMDLs are involved in multiple levels of regulation of SPT. A direct and rapid inhibition by ceramide, and the loss of that regulation when the ORMDLs are degraded as a result of interrupted S1P signaling. There is doubtless more to come and we look forward to further discoveries illuminating regulation of this essential system and the physiological impact of that regulation.

    1. On 2018-07-27 00:19:01, user markyz wrote:

      Very interesting paper. I was wondering whether you tested the accuracy and speed of the gene counts that are provided by STAR aligner, which eases i/o demands during data processing. Here is an example of how it can be run.

      STAR --runThreadN $THREADS --quantMode GeneCounts --genomeLoad LoadAndKeep \ --outSAMtype None --genomeDir $STAR_DIR --readFilesIn=$FQ1 $FQ2<br /> Mark Ziemann, PhD

    1. On 2020-02-17 13:53:52, user SummerBreeze wrote:

      1. Background: The morphologic-colloquial classification*... [The taxonomic is of great discussion but according to McPartland et al, all Cannabis is taxonomically sativa.]
      2. [Polymorphic SNP is redudant.]
      3. "...with terpinolene (colloquial 'sativa' or 'NLD', myrcene/pinene and myrcene/limonene (colloquial 'indica', 'BLD')" [...Are genotypes and phenotypes a colloquial declination? I would agree with Expression but not cluster correlation.]
    1. On 2021-09-13 22:31:04, user tetech2 wrote:

      The stem cell tumor problem is having to be addressed:<br /> Identifying alterna-<br /> tive reprogramming strategies to restore youthful gene<br /> expression with lower neoplastic risk is therefore desirable.<br /> Toward this aim, we have shown that transient reprogram-<br /> ming with multiple subsets of the Yamanaka Factors in-<br /> duces highly similar transcriptional effects to the full set,<br /> and that a distinct multipotent reprogramming system can<br /> confer youthful expression. These results suggest the fea-<br /> sibility of disentangling the rejuvenative and pluripotency<br /> inducing effects of transient reprogramming and serve as a<br /> resource for further interrogation of transient reprogram-<br /> ming effects in aged cells.

    1. On 2020-03-27 05:12:57, user Steve Lilac wrote:

      EMT as a mechanism of trastuzumab and lapatinib resistance. In my opinion the question why in breast cancer epithelial cells are mostly HER2-high and mesenchymal cells are HER2-low is deliberated and perfectly investigated. Answer: because of different chromatin architecture. The paper is suggesting that HER2 gene stands with epithelial phenotype and can be silenced during EMT similar to other epithelial marks. When an epithelial HER2+ cell undergoes EMT, the cell looses HER2 expression due to chromatin closure . Quite sensible. The most parts of study is done on genomics and epigenomics data from depositories which is impressive. I think this is a great example for how different raw data are to be analyzed in a correct way by other researchers to compile meaningful results. The in silico data contains those from patients and cell culture that is confirmed by experimental results.

    1. On 2019-10-10 13:50:21, user Sebastian Pfeilmeier wrote:

      Endophytes are getting into the focus of microbiota research, as they are in close contact with the plant and both organisms are likely to influence each other. I was wondering whether it would be even more informative to compare not only "diversity" of different plant species and tissues, but also look for high abundant taxa that are commonly found as endophytes in plant species/tissue. After doing the effort of collecting all the rawdata from various studies, would it be possible to do this analysis?

    1. On 2023-06-20 06:12:32, user jean-philippe hugnot wrote:

      This article is now published:

      Ripoll, C., Poulen, G., Chevreau, R. et al. Persistence of FoxJ1+ Pax6+ Sox2+ ependymal cells throughout life in the human spinal cord. Cell. Mol. Life Sci. 80, 181 (2023) doi: 10.1007/s00018-023-04811-x.

      The article has been upgraded with new figures and data and some errors present in figures and supplementary figures in the Biorxiv version have been also corrected.

      JP Hugnot

    1. On 2025-04-10 12:53:55, user Huiwang Ai wrote:

      I think the authors just don't understand computational protein design. RFdiffusion is used to generate the shape of the binder, not sequences. You then need other follow-up computational tools.

    1. On 2023-09-19 18:56:14, user Lloyd Fricker wrote:

      Confirmation of results is an essential part of science. Our original finding that the peptide PEN is an agonist of GPR83 was already verified by two different laboratories (see Foster et al, 2019, “Discovery of Human Signaling Systems: Pairing Peptides to G Protein-Coupled Receptors”, Cell, PMID: 31675498; and Parobchak et al, 2020,<br /> “Uterine Gpr83 mRNA is highly expressed during early pregnancy and GPR83 mediates the actions of PEN in endometrial and non-endometrial cells”, FS Science, PMID: 35559741). However, when another laboratory can’t confirm what was published, it is important to consider differences between the studies. With this in mind, there are several issues with the study presented here in the BioRxiv report by Giesecke et al. Additional experiments described below would be very helpful.

      The HEK293 cell line has been reported to express GPR83 mRNA in many studies listed in GEO Profile, and this is confirmed in the current study (Figure 1A). In the figure showing overexpression of HA-tagged GPR83 in HEK293 cells, the distribution is largely intracellular, maybe ER or Golgi (Figure 1B). Thus, it’s not relevant to consider ‘100-fold’ overexpression based on mRNA, as the amount that is correctly folded and expressed at the cell surface may not be much different than in the native HEK293 cell line. Furthermore, the authors show that PEN peptide does produce a robust increase in phosphoERK in Figure 4A (compare the lanes labeled ‘control’ and ‘PEN’). Furthermore, it looks like the PEN-mediated increase in phosphoERK is several fold higher in GPR83-transfected cells than in control cells (Figure 4A). Although the quantitation panel in Figure 4B doesn’t show an increase, there are very large ‘error bars’ reported to be SD, but for N=2 doesn’t SD really mean the range of duplicates? Also, please show all data points in the bar graph! In any case, it would be nice to see a larger N for these studies. But best of all would be a knock-down of GPR83 in HEK293 cells using siRNA, or a related approach.

      Another point is that in the PEN-GPR83 peptide-receptor system, signaling assays that are distal to the receptor activity (cAMP, PLC) tend to give variable results – this has been previously noted in our original study (Gomes et al, PMID: 27117253). This also appears to be the case with the TANGO assay where we have recently found that long-term treatment with PEN (16 hrs) causes a desensitization of the receptor leading to a complete loss of signal (our unpublished observations). There are also issues with the concentration dependence, and ‘u-shaped’ curves where high concentrations of PEN fail to produce the effects seen with lower concentrations (PMID: 27117253). The authors should repeat the studies with shorter times and lower concentrations of PEN.

      The lack of binding with Tyr-PEN seen by Giesecke et al. could be due to the presence of an internal His residue in human PEN (YAADHDVGSELPPEGVLGALLRV). Tyr-PEN used in our previous studies for iodination was the rat sequence, which does not have a His. Because His residues can be iodinated using the chloramine T procedure used by Giesecke et al, this can potentially affect binding. It would be good to test binding with iodinated rat Tyr-PEN, to avoid the His residue. Also, why the C-term amide group? That’s not part of PEN.

      For the Ca++ assays, Giesecke et al. used G?16, but our previous studies used G?16/i3 (PMID: 27117253). This is not a minor difference. Ideally, Giesecke et al could repeat the experiments with G?16/i3.

      Finally, protease inhibitors were used in the binding studies by Giesecke et al, which is good. It is not clear if such inhibitors were used in all other studies with PEN, such as those described in Figure 2 and 3. In the absence of protease inhibitors, PEN could be degraded during the assays and this could have accounted for the negative results.

      Sincerely,<br /> Ivone Gomes,<br /> Lloyd Fricker,<br /> Lakshmi Devi

    1. On 2020-05-02 01:51:05, user Paul Wolf wrote:

      The big question right now is what was the intermediate animal that tranferred covid-2 from bats to humans. This study was about ferrets, which is one possible vector, since this is how the scandalous gain of function research works. Once a virus spreads on its own throughout a ferret population, it has adapted to the ferret which is apparently similar to the human system.

      I wonder why pangolins weren't included in this study? Is there some reason to believe covid-2 was transmitted by cats and ducks? The pangolins receptors are apparently a close match to covid-2's, which is where this theory came from, that it came from a seafood market that sold them. But it's not known whether pangolins can actually be infected with covid-2.

    1. On 2019-05-26 22:16:50, user DeboraMarks wrote:

      Dear Authors

      You might want to consider comparing your approach for variant prediction to results from following two paper: plausibly the state-of-art for variant prediction from sequence:

      1. The unsupervised probabilistic modeling in of Hopf, Ingraham et al., " Mutation effects predicted from sequence co-variation" Nature Biotechnology Jan 2017 https://www.nature.com/articles/nbt.3769 . <br /> Compared to 33 deep mutational scans.

      2.( Unsupervised) Variational autoencoder, Riesselman, Ingraham, Marks "Deep generative models of genetic variation capture the effects of mutations" . Nature Methods 2018 <br /> https://www.nature.com/articles/s41592-018-0138-4<br /> Compared to 40 deep mutational scans

      https://uploads.disquscdn.c...

    1. On 2018-04-26 06:36:20, user pierre wrote:

      Hi there, <br /> Thanks for this nice work. Would it be easy to test several of your experiments comparing with Simka [1] instead of Mash? Both tools are based on kmers comparisons, but Simka does not subsample input data, and thus reaches a higher precision.

      Have a nice day, <br /> Pierre Peterlongo

      [1] Benoit, G., Peterlongo, P., Mariadassou, M., Drezen, E., Schbath, S., Lavenier, D., & Lemaitre, C. (2016). Multiple comparative metagenomics using multiset k-mer counting. PeerJ Computer Science, 2, e94.

    1. On 2016-07-30 13:34:21, user Paul Janssen wrote:

      A darn pitty that this new platform is only available for researchers <br /> and research groups in the UK - one may wonder whether in response the <br /> UK should be excluded from access to the renowned EMBL resources (www.embl.de) paid by European money .... and whether the EBI (http://www.ebi.ac.uk/) "http://www.ebi.ac.uk/)") should be relocated to Belgium or elsewhere on the main continent !!!

    1. On 2017-04-29 14:50:47, user Vladimir Panchev wrote:

      This article contains some very important approaches that could help to overcome two tremendous fallacies relating the stomata with the two essential and vital for the plant mechanisms, the supply of water and CO2 for photosynthesis and phloem sap formation. Yet the title implies that the early stomatal closure is vital for surviving in drought which means that their openness is not vital for the plant. This is in accord with the auhors' Ref. 10 which they cited without pointing out that it reports that in very low stomatal conductance (which shell mean also in complete closure), CO2 is not limiting factor for photosynthesis, not mentioning also the water for such one. Does it not mean that both photosynthesis stuffs come from below, without any vital dependence on stomatal opening? In support of this conclusion, having regard that in nature drought can last months and years with stomatal full closure, does the common sense allows to assume that plants can survive such periods without photosynthesis and sap circulation, if water and CO2 supply depended on stomatal opening? Does this only fact (apart from the huge number of others that we can present) is not sufficient to convince the reader that the key role of open stomata for water an CO2 supply, which the two dogmas ascribe to them is one of the most deleterious fallacies in the entire science, not only in the plant physiology?<br /> Very recently appeared two articles which support Martin-StPaul, et al.’s important conclusion for the vital importance of early stomatal closure during drought. In the first one, Scoffoni et al. (2017) inform that “Outside-xylem vulnerability, not xylem embolism, controls leaf hydraulic decline during dehydration”. The authors established that the decline of leaf hydraulic conductance during dehydration arose first and foremost due to the vulnerability of outside-xylem tissues. We think that for everyone, who is sufficiently familiar with physics, should become clear that, if the outside xylem first dehydrates, the stem xylem embolism during severe drought cannot in any kind be caused by the increased tension produced by the increased “water potential difference between leaves and soil”, as the modern Cohesion-Tension theory (C-TT) (which, on our mind, Martin-StPaul et al. rightly not cited) implies. Is it not quite clear that, if the plant dead occurs by stem embolization, according the C-TT, leaves must dehydrate and die the last, after consuming the entire water above the hypothetical place of water thread disruption? (If C-TT leaves something for leaves' consumption, because it postulates that the drawn up water is entirely evaporated?) Evidently, not realizing that their finding undermines C-TT, Scoffoni et al. (2017) try to present their finding as safety mechanism to prevent xylem embolization. Could the leaves die to prevent xylem sap interruption, or how wilted leaves before dying could resume water transport after watering, if for resuming evaporation and sap pulling they mus firstly regain turgidity?<br /> We think that the fallacious implication that the increased tension during drought produces xylem embolism which is the cause of plant dead is entirely based on the fallacious assumption which Scholander et al. (1965) introduced after diametrically changing their minds from Scholander et al. (1955 and 1962). Using metal (instead of Dixon’s glass chamber) they misled the entire community that the measured in the pressure bomb pressure is the negative pressure in the xylem conduits, thus, reviving the more than half a century almost dead theory. Their opaque (instead of Dixon’s transparent chamber) hides from the users’ eyes the extremely important “striking fact” that Joly reported during the first discussion on C-TT (Darwin, 1896) (entirely neglected). It was that during increasing and relieving the pressure in the glass chamber, the leaf behaves like a Bourdon tube rolling inwards from the edges and simultaneously dropping upon the petiole. This means that plant leaves cannot sustain xylem-to-atmosphere pressure differences, because in such conditions their veins behave as real Bourdon tubes.<br /> Other arguments against the pressure-chamber-technique, which Scholander et al. (1965) introduced, stem from Scholander et al.’s reports themselves. In Scholander et al. (1955) there are at least three very important anti-C-TT reports: The first is that, based on direct measurements, they excluded significant negative pressures, establishing that spring refilling is caused by strong positive pressures; The second is that from the cut grapevine stem all water till the next upper bordered pit goes freely out which points on the absence of sufficient wettability, but, we assert, also that this proves that bordered pit membranes serve as one-way valves, preventing sap back flow; The third is that grapevine’s xylem sap is fully saturated with atmospheric nitrogen in the roots, without releasing it in the conduits (why, if xylem sap is tensile?).<br /> The reader is also invited to look at the conclusion made with the last sentence of Scholander et al.’s (1962): “The root system of mangroves is ventilated by air, and it seems more likely that the separation involves a case of active transport”. Is this consistent with the modern C-TT which teaches that cohesion-tension continues drawing water in the roots? It is interesting that even with their above cited three-years-later publication (Scholander et al., 1965) with which they mislead the world with the revival of this technique for indirect measuring “negative pressures”, disregarding their above cited 1955 and 1962 anti-C-TT results, they gave serious ground to disbelieve their assertion. In Scolander et al. (1965) abstract they write: “In tall conifers there is a hydrostatic pressure gradient that closely corresponds to the height and seems surprisingly little influenced by the intensity of transpiration”. Is it not quite similar to the below cited Dixon (1898, 1914, 1938) conclusion rejecting evaporation? This “surprise” is ignored yet half a century. Moreover, we assert that the last two sentences of that abstract prove that the method does not show any tension, but the ultrafiltration via the cell membrane against the osmotic pressure suggested by Askenasy (1895) cited below. We stress that in the presently mechanistically repeated C-TT variant the also mechanistically cited its original authors are represented only by the tension because:<br /> 1. One of the authors of the original C-TT, H. Dixon, (that Scoffoni et al., 2017 cited), cannot be linked with the modern C-TT, because very soon he realized that Strasbuger’s experiment with the dead tree was misleading with the following statement first made 120 years ago: “With regard to the elevation of water, when the leaves are surrounded by an unsaturated atmosphere, we cannot as yet be dogmatic. But the fact that, when the leaves of plants are killed, they dry up and are unable to furnish themselves with sufficient water from unlimited supply at the base of their stem, argues that surface tension and evaporation forces at their surfaces are in themselves inadequate” (Dixon, 1898, p. 634, 1914, p.24, 1938)?<br /> 2. The present C-TT is also inconsistent with the opinion of the other, also widely believed as the original C-TT author, E. Askenasy, who yet in his first paper (Askenasy, 1895) stated that in the “living, not wounded” plants water enters the roots by osmosis, not by tension? Yet in this first paper, he opposed the leaf surface tension in the non-existing water menisci three years earlier than the above mentioned Dixon’s change of mind. In the same paper, Askenasy suggested evaporation through the cell wall with subsequent imbibition by osmosis, instead of the original Dixon and Joly’s (1895) C-TT which nowadays continues to be described as the sole and absolute truth based on non-existing structures. This was confirmed by the second above mentioned recent report, Buckley et al. (2017) who proposed a mixed-phase water transport outside the xylem, evidently not suspecting that they definitively undermine modern C-TT which relies on tension created on hypothetical water menisci formed between the spongy mesophyll cells. Apart that spongy mesophyll cannot sustain tension, could mixed gas-water phase transmit tension?<br /> References:<br /> Askenasy E (1895) Über das saftsteigen. Ferh. Naturh-med. Ver. Heidelberg N. F. 5: 325-345<br /> Buckley TN, John GP, Scoffoni C, Sack L (2017) The Sites of Evaporation within Leaves. Plant Physiol; 173: 1763-1782<br /> Christine Scoffoni et al. (2017) Outside-Xylem Vulnerability, Not Xylem Embolism, Controls Leaf Hydraulic Decline during Dehydration. Plant Physiol. 173: 1197-1210<br /> Darwin F (1896) Report of a discussion on the ascent of water in trees. Ann Bot os-10: 630-661<br /> Dixon HH, Joly J (1894) On the ascent of sap. Proc Roy Soc London 57: 3-5<br /> Dixon HH, Joly J (1895) On the ascent of sap. Phil Trans Roy Soc London 186: 563- 576<br /> Dixon HH (1898) Transpiration into a Saturated Atmosphere. Proc Roy Irish Acad 4: 627-635<br /> Dixon HH (1914) Transpiration and the ascent of sap in plants. Proc Roy Soc London<br /> Dixon HH (1938) The Croonian Lecture: Transport of Substances in Plants. Proc. Roy Soc London 125: 1-25<br /> Scholander PF, Love WE, Kanwisher JW (1955) The rise of sap in tall grapevines. Plant Physiol 30 (2): 93-104<br /> Scholander PF, Hammel HT, Hemmingsen E, Garey W (1962) Salt Balance in Mangroves. Plant Physiol 37: 722 -729<br /> Scholander PF Bradstreet ED, Hemmingsen EA, Hammel HT 1965 Sap Pressure in Vascular Plants. Negative hydrostatic pressure can be measured in plants. Science 148: 339-346<br /> Vladimir S. Panchev<br /> Adelina V. Pancheva<br /> Marieta V. Pancheva

    1. On 2018-09-27 20:54:37, user Nils Homer wrote:

      Definitely looks promising!

      Needs references to the current standards (ex. the Li et al SAM paper). Needs references to the current reference implementations (ex. htslib, htsjdk); "currently-needed functionalities" already supported by these; why isn't the reference implementation contributed to those existing projects with already used APIs? Hopefully the current spec maintainers are asked to be reviewers.

    1. On 2025-05-02 12:25:59, user Matt Agler wrote:

      The authors note that it has been brought to our attention that we used the wrong form of the glycoside in Fig 6. The figure uses the L- and not the D-form. We will update the figure in the next round of revisions when we update the manuscript.

    1. On 2019-08-07 23:22:57, user Laura Sanchez wrote:

      The manuscript by Marchione et al. describes a novel and exciting method to perform proteomics on archived FFPE tissue. The manuscript is thorough and did not over or understate the value of the findings. The method appears to have broad implications for the use with archival FFPE samples and importantly, does not require great measures or lengthy extra steps in order to achieve proteomic quality achieved with fresh frozen tissues. It was noted that a broad extension could be to incorporate this workflow with FFPE tissue blocks that are being used for imaging mass spectrometry workflows. Coupling the spatial information with the IDs from the HYPERsol workflow would be incredibly powerful for clinical applications. We appreciated the use of color coding and acronyms to attempt to simplify the readability of the manuscript, however we do have suggestions which may improve this further. The supplemental figures were well done and the overall consensus was that some of them may be better suited as main figures although we realize this may be a journal specific limitation on the number of figures that could be included. A full list of major and minor critiques is listed below with hopes that this may help the authors improve readability and strengthen the findings.

      Major:<br /> The reference to “flash-frozen results” in the title is not abundantly clear to refer to the FFPE results as having comparable quality to flash-frozen tissue results. Rewording the title would help with clarity.

      Figure 1e is missing a figure legend.

      Assumed level of knowledge with how tissue samples are usually handled for proteomic experiments is very high, but we are unsure of who the target audience is. Additional references or explanation could help broaden the audience.

      In paragraph “in order to compare” on page 2, it does not comment on limitations of HYPER-Sol. It would be helpful to know what protein categories (if any) are missing in HYPER-sol as represented in figure 2f, because a large list of Protein ID’s is difficult to dig through and it is not abundantly convincing that the missing proteins are simply noise.<br /> Acronyms are not consistently used throughout the paper. Mentions of XPM could also be widely replaced as “standard”, and DAS with HYPER-sol. Figure 1b could also benefit from having some sort of legend for the conditions or having them appear directly in the table similarly to how they are depicted in the text on page 1.

      We were very interested in the claim that TLE1 expression was only 3-fold more expressed than MPNST. Supplementing the mass spectrometry experiments with immunohistochemistry would be a strong orthogonal validation that the MS method is indeed robust.

      The limitations of extending HYPER-sol to historical samples should be further articulated. For instance, even though all of these historical tissues exist, researchers may run into issues finding the metadata due to a lack of historical medical records for archived tissue, thereby limiting the usefulness without the biological context. Perhaps, this can also be framed as a push to digitize existing historical records?

      Minor:<br /> Being able to process a 17 year old sample with HYPER-sol is a highlight of the applications of HYPER-sol. Mentioning the historical samples in the abstract would increase interest in the manuscript.

      Mixed feelings on use of informal terms such as “gold-mine” and “treasure trove” (pg 1): these could be replaced with “resource”. This terminology is not scientific.

      Imaging mass spectrometry specialists routinely use solvents to access FFPE tissues and to call them toxic chemicals may be an overstatement.

      Please clarify how much dry mass was used from the historical sample, and if that amount consumed the whole sample. A reference is made to 5 mg in Figure 1, but it is unclear whether or not that amount was also used in the historical sample. Also, were the historical tissues from tissue blocks or from stored tissue? This was not clear in the experimental details.

      Figure 1b uses “X”s in the table, even though X is a common abbreviation in the paper. Consider using check marks or another indicator instead.

      Figure 1b should include all conditions with acronyms that are referenced in the paper. For example FAS and XAS are not listed here but are mentioned in future parts of the manuscript, this would greatly increase readability.

      The spectral libraries referred to in “Mass Spectrometry data analysis” seem to be produced from flash-frozen tissue, but it would be beneficial to specify that this is the case given the variety of possible sources for a spectral library in the figure legend in which it is referenced.<br /> In supplemental figures 1a and 1c, what is the non-soluble material? It is also not clear what the normalization process is for relative residual pellet masses.

      In supplemental Fig 2, consider pairing the X-axis so that tissue sources line up between the two graphs. Another option would be to overlap the graphs, where yield and percent solubilized data points have different shapes. We would suggest keeping figure 2b’s X axis in the original order and layering the data from figure 1a on top.

    1. On 2020-07-31 17:28:29, user Davidski wrote:

      Hello authors,

      Thanks for the interesting preprint. On first inspection, however, there are a couple of issues with the geographic terms in your paper.

      Now, I know that you're trying to come up with terms that fit geography, archeology and genetic clusters, but these examples really stick out as being misleading:

      • most of the samples that you put into the PC steppe category (figure 2 F) aren't from the Pontic-Caspian steppe, which is located in Eastern Europe. They're actually from the Kazakh steppe, which is located in Central Asia. See here...

      https://en.wikipedia.org/wi...

      How about if you refer to this grouping as "Western steppe"? This is actually what it is, because the term Western steppe includes both the Pontic-Caspian steppe and the Kazakh steppe.

      • most of the samples in your Central Asia grouping aren't really from Central Asia. They're actually from West Asia, because Iran is most certainly located in West Asia, not Central Asia. Alternatively, you can call this the Iran-Turan cluster.

      As I said, I do realize that this is a genetic paper, not a geographic paper. But you can't shift the location of a major geographic feature, like the Pontic-Caspian steppe, almost entirely from one continent to another without people noticing that something is way off, and thus possibly extrapolating that the rest of your paper is not reliable. Cheers

    1. On 2019-06-20 09:17:16, user John Aplin wrote:

      How confident are you that Epi9 is a ciliated cell? It is distant from other ciliated groups in the SNE. It is hard to see in your colouring scheme in Fig 2 how it maps in the pseudo time analysis -- is it at the most distant (left hand) end of the secretory cell repertoire? Do you think that ciliated cells are also secretory?

    1. On 2023-09-10 19:39:50, user Wenderson Rodrigues wrote:

      Dear Authors,

      I am Wenderson Rodrigues, a Ph.D. student at the Federal University of Minas Gerais (Brazil), affiliated with the Plant Interaction Laboratory (LIVe). My research project focuses on the study of ncRNA in the interaction between parasitic plants and host plants. Our laboratory has initiated an activity called the "Preprint Club" where we train and learn to review preprints relevant to our research areas. I have selected your preprint titled "Long noncoding RNAs emerge from transposon-derived antisense sequences and may contribute to infection stage-specific transposon regulation in a fungal phytopathogen" for reading and critical review.

      In this manuscript, Qian and colleagues conduct an extensive study on the identification, classification, and investigation of transposable elements (TEs) and ncRNAs in the genome of Blumeria hordei, a powdery mildew fungal pathogen of Hordeum vulgare (Barley). This is a highly interesting manuscript; the methods are well-documented in the literature, and the results are significant. In my opinion, the authors could provide more information in the Introduction about the infection cycle of B. hordei, as understanding this pathogenic process is crucial for interpreting the presented results. Additionally, here are some specific comments regarding questions and corrections that seemed pertinent to me during my reading.

      Specific comments:<br /> Lines 135-136: The presentation of PC and NMDS analyses is confusing in terms of result interpretation because they do not complement each other, as mentioned in the text. How do the NMDS results influence the interpretation of the PCA results?

      Lines 172-173: For the 102 TEs, where is the expression data?

      Lines 181-183: How did you identify if they are peptide-coding transcripts, and what criteria were used to evaluate their significance?

      Figures 3B and C are not mentioned in the text. Figure 3D should be reversed in terms of read mappings to follow the order of citation in the text (RNA-Seq and ONT), or the text could be modified to maintain the order of appearance in the figure.

      Lines 203-204: There seems to be a missing punctuation mark in the text.

      Line 208: Although Figure 4 is mentioned to display information about the lncRNAs identified in the study (such as exon numbers and size), it might be better to specify in which section of Figure 4 this information can be found, e.g., Figure 4B-C.

      Lines 233-234: How were the analyses for the identification of putative secreted proteins conducted? Was there a pipeline used for identifying such proteins?

      Lines 293-294: The text appears incomplete, possibly due to a typing error.

      These are some points that I found relevant to convey to the authors. The research in this preprint is impressive, and it was a pleasure to read and learn from the authors.

      All the best,<br /> Wenderson Rodrigues.

    1. On 2016-08-24 20:55:25, user Tal Yarkoni wrote:

      This is an innovative and very thought-provoking paper that will hopefully be widely read by researchers working with fMRI. I have two general comments with respect to the authors' main thesis:

      1. As far as I can tell, the authors don't motivate the decision to focus exclusively on sub-voxel representations. They point out that non-smooth sub-voxel representations would be impossible to detect with fMRI, which is an important observation. But surely non-smooth *supra-voxel* representations would still be easily detectable with fMRI. A priori, there doesn't seem to be a good reason to rule out this kind of representation in the brain. As far as I can tell, representational similarity analyses would still work successfully if the brain were composed of hundreds of functionally discrete tiles that were non-smooth at both the sub-voxel and supra-voxel levels. This doesn't seem like a far-fetched possibility; for example, suppose that when people think about penguins, they're somewhat more likely to think about the unusual climate in which penguins live. Representations of climate may be non-smooth, yet reside in fundamentally different brain circuits from representations of physical shape, size, etc. One consequence would be that neural representations of robins would almost certainly more closely resemble those of sparrows than those of penguins even if there were no spatially graded sub-voxel representations at all in the human brain--simply in virtue of sharing a larger number of salient properties with the former than the latter. Of course, I'm not suggesting that there _aren't_ smooth sub-voxel representations in the brain, but simply that the authors conclusion that "the neural code must be smooth, both at the subvoxel and functional levels" doesn't necessarily follow.

      2. Even if one assumes that the signal detected by fMRI is in fact driven entirely by smooth sub-voxel representations, it still wouldn't follow that the neural code must be smooth at the sub-voxel level. All we would be able to conclude is that there is at least *some* component of the signal that is smooth. This would not preclude other neural codes from existing, and in fact, we already have abundant evidence of non-smooth sub-voxel representations. For example, ocular dominance columns clearly exist, and if fMRI is unable to detect them, that reflects a limitation of fMRI, not a generalizable claim about the way the brain represents information. While I'm not a systems neuroscientist, I would imagine that there are any number of examples in the systems neuroscience literature of non-smooth, but highly structured sub-voxel representations that would probably be completely undetectable with fMRI. So I think the authors may want to be more circumspect about the conclusions they draw. Their results don't really show that only a subset of neural coding schemes are plausible; rather they suggest that whatever neural representations fMRI is capable of detecting are likely to stem from either (a) smooth representations (either sub- or supra-voxel) or (b) non-smooth supra-voxel representations. This leaves open the possibility (and it seems like a very real one) that the vast majority of information represented in the brain is not represented in a way that is amenable to detection with fMRI.

      Setting these concerns aside, I think this is still a paper that should be of great interest to most cognitive neuroscientists. One point that is made very elegantly here is that the nature of neural representations does not have to be (and probably isn't) uniform across the brain. In particular, the authors put forward a compelling argument for the possibility that brain regions higher in the processing stream--and that are more likely to represent very abstract, multidimensional information--may not be amenable to imaging at all. This point should give many fMRI researchers pause when considering studying, e.g., the representational structure of prefrontal cortex. At the very least, the manuscript raises a number of important questions that should spur further discussion within the neuroimaging community.

    1. On 2022-01-24 16:16:01, user Andre Schwarz wrote:

      Dear Liang, Julia, and colleagues,<br /> Beautiful and exhaustive work. This will definitely serve as a standard for future work.<br /> I presented this work today in our journal club (it was very well received) and wanted to share some of the comments with you: <br /> 1) In order to address how much of the absent elongation states upon antibiotic treatment are due to reduced particle number, could you repeat the same classification with a subset of the untreated dataset? I.e. take 13,418 (as in SPT) or 21,299 (as in Cm) particles of the untreated dataset, repeat the classification, and see<br /> how many classes you get?<br /> 2) To independently validate your visual polysome classification/assignment, could you run a polysome gradient and see whether the numbers of di-, trisomes, etc. roughly agree?<br /> Best wishes,<br /> Andre

    1. On 2018-05-12 13:20:33, user Atul Butte wrote:

      You guys might be interested in our paper on 3 phenotypic subtypes on getting type 2 diabetes

      https://scholar.google.com/...

      Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis

      Keiichi Kodama, Damon Tojjar, Satoru Yamada, Kyoko Toda, Chirag J Patel, Atul J Butte<br /> Diabetes care 36 (6), 1789-1796, 2013.

    1. On 2020-01-16 03:00:34, user David Ron wrote:

      The theme of co-evolution, as it relates to the recognition of JDP and Hsp70 is nicely developed in this scholarly paper. It might be interesting to consider the suppression of the DnaJ D35N mutation by DnaK R167H, alluded to in the discussion, as a case of co-evolution affecting the mechanistic step. It might be helpful were the authors to digress further on the basis of the functionality of the R167H mutation in DnaK? Does it maintain the interaction with D517-SBD and D429-linker? How does it suppress the HPD to HPN mutation? Could this pair serve as fodder for an MD simulation such as the one presented for the wildtype DnaK/DnaJ pair in figure 2b?

    1. On 2020-10-07 23:47:22, user UAB BPJC wrote:

      Review comments on “Staphylococcus aureus secretes immunomodulatory RNA and DNA via membrane vesicles” by the University of Alabama at Birmingham Bacterial Pathogenesis and Physiology Journal Club

      Summary: This paper discusses how S. aureus is able to secrete extracellular membrane vesicles (MV) that contains immunomodulatory RNA and DNA and their delivery to intracellular host receptors.

      This paper has very easy to read language and little use of jargon which is nice to find in scientific papers. The methods are described in much detail which is very nice. However, it is a bit long, especially the results section. Some of the details in the results may be better suited to be added to the either the introduction or discussion. For example, line 116-117 “it is conceivable that nucleic acids could be released through spontaneous phage-dependent or independent cell lysis” would be better suited in the discussion than in the results. The conclusion that RNA packaged in MVs from S. aureus has immunomodulatory effects is very interesting! It is also neat that there is currently a paradigm shift in that endosomal TLRs are not just signaling for IFNb in viral infections and this paper is playing a role in that shift. This paper could be more impactful if some of the current figures were added to the supplement and addition of experiments with more controls and addition of sequencing RNA/DNA as well as looking at which proteins are packaged in these MVs and whether of not they are playing any immunomodulatory roles. Additionally, the immunofluorescent images in this paper are beautiful.

      Major points:

      * Biological vs technical replicates are not clear which is used in each figure.

      * What are these RNAs that are in the MVs? Are they random or purposely packaged specifically? Sequencing these RNAs as well as DNAs would add very valuable information.

      * A readout of mRNA levels of IFNb is informational but there would be more value/impact if ELISAs to look at the effect on protein levels would be add value

      Minor points:

      Figure 1: S. aureus release MVs enriched in proteins and nucleic acids. <br /> * Panel A<br /> o Bradford assay is not the best at detecting levels of proteins in lipid rich conditions<br /> o This graph should be separated by each of the components protein, lipid, DNA, and RNA because relative fluorescent levels would not be the same for each of these components and comparisons between macromolecules cannot be done. This maybe better to show separated by macromolecule rather than by fraction.<br /> o Additionally, the label relative fluorescence levels is misleading because the Bradford readout is colorimetric and not fluorescent. <br /> o It is not clear what the normalization is. What is 100% in the peak fraction for each method?

      * Panel B<br /> o Negative stained TEM images of purified MVs are not very clear. Are there better ways to show this? Perhaps just using membrane staining dyes and fluorescent images? <br /> o The scale bars are appreciated

      * Panel C<br /> o This may be better suited as supplemental data

      * Panel E<br /> o This is a common issue throughout the paper, it is not clear whether representative of “3 independent experiments” means that we are seeing all the data from all 3 experiments or just from 1. It would be nice to know whether these are biological replicates or technical replicates. <br /> o Another issue throughout the paper is that only mRNA is shown for the changes in IFN-b. It would be nice to show protein changes as well via ELISA. <br /> o This data are very interesting!

      Figure 2: Purified S. aureus MVs induce significant IFN-b mRNA expression in cultured murine macrophages. <br /> * RAW264.7 cells are a macrophage-like cell line but are not actually macrophages. <br /> * A and B are nice to see how you decided on using 5ug and 3h timepoints but this data could be added to the supplemental <br /> * Again, not clear if technical or biological replicates and in C it would be good to add an ELISA to further validate your results.

      Figure 3: Detergent, Benzonase, and Proteinase K sensitivity of MV-associated Nucleic Acids and Figure 6: Benzonase-treatment reduces MV-mediated IFN-b mRNA expression in macrophages<br /> * Combining of this figure and Figure 6 would make more sense, especially since your diagram of how Benzonase treatment of MVs affects the RNA isn’t until figure 6 but you use the Benzonase in Figure 3. <br /> * Additionally, in Figure 6b there is no untreated control which would be valuable. <br /> * How do you explain the decrease in nucleic acid levels in Benzonase treated MVs if you are claiming that MVs protect the RNA from this kind of degradation later on in the paper?

      Figure 4: The RNA content of S. aureus MVs consists of Benzonase-sensitive and Benzonase-resistant subpopulations and Figure 5: the DNA content of S. aureus MVs is resistant to Benzonase treatment. <br /> * These figures could be combined into one figure because they address the same point. <br /> * Technical vs biological replicates?<br /> * Can you sequence the RNA/DNA isolated from these analyses? If C is averages of triplicate experiments wouldn’t it be more valuable to show all the data points and not just the averages?

      Figure 7: Dynamin-dependent endocytosis is likely involved in MV-mediated induction of IFN-b in RAW264.7 cells<br /> * Figure 7a lacks an untreated control for dynasore and bMVs treatment<br /> * Dynamin is involved in other processes besides endocytosis, how can you be sure this is not affecting your results?<br /> * B would be nicer if you could show bafilomycin and chloroquine with the inhibitory arrow/line directly on the endosomal acidification instead of the arrow<br /> * C lacks bMVs only control <br /> * Bafilomycin has off target effects on IFNb so you would need to also do bafilomycin and chloroquine only controls to verify the effect you have is directly because of acidification.

      Figure 8: MV-associated RNA induces IFNb largely through endosomal TLR signaling in murine macrophages<br /> * Again, it would be nice to see each data point represented and not just the means of the experiments. <br /> * 8A is very nice, especially the usage of the cGAMP control. <br /> * This figure has some really interesting data! <br /> * In B, why did you do only an IRF3 and IRF7 KO but did not include a TLR 9 as well?<br /> * The breaks in the axes in C-E can make the changes look more meaningful than they actually are especially since the scales are different in all 3 graphs

      Figure 9: Treating MVs with benzonase reduces the IFNb mRNA expression in both WT & TLR3-/- macrophages compared to macrophages stimulated with untreated MVs<br /> * The difference in treatment of TLR-/- cells with MV vs bMVs was not explained<br /> * Neat results!

      Figure 10: S. aureus bMVs and their associated RNA cargo is delivered into wildtype macrophages <br /> * Beautiful images!<br /> * It would be nice if you could include quantifications of the colocalization of MVs and RNA for both A and B<br /> * Are the scale bars for A and B accurate? Looking at the macrophages in the bottom right corner of both A and B, they look like vastly different sizes even though the scale shows that they are in the same scale.

      Figure 11 <br /> * Nice schematic! <br /> * Are you showing Bafilomycin and chloroquine disrupting the TLR signaling separately of endosomal acidification? <br /> * Maybe show that the endosomal acidification impacts the levels of IFN

    1. On 2022-08-03 21:21:03, user smartalec wrote:

      page 8: "The identity of potential drivers of SCLC metastasis on chromosome 16p, the top gain (Supplementary Fig. S7B), remains unknown, but genomic gain of 16p13.3 has been associated with poor outcome in prostate cancer (48) and this region contains the PDK1 gene, coding for a component of the PI3K/AKT pathway." Its not PDK1 which lives on Chr2. The correct gene is PDPK1.

    1. On 2025-05-07 00:48:26, user Young Cho wrote:

      The paper focuses on the discovery and synthesis of small molecules that target the p300 histone acetyltransferase (HAT), a key enzyme involved in epigenetic regulation. The researchers identify a series of N-phenylbenzamide analogs, including activators (YF2, RA010900, RA010160, RA010168) and inhibitors (JF1, JF10, JF16), exploring their effects on lysine acetylation of histone 3 at residues K18 and K27. Through structure-activity relationship (SAR) analysis, the study found that the alkyl side chains and specific substitutions on the N-phenylbenzamide scaffold critically influence whether a compound activates or inhibits p300. Despite its poor metabolic stability and rapid degradation in human and murine liver microsomes, YF2 emerged as the lead molecule for its strong activation profile.

      The paper effectively supports its conclusions through clear data presentation, including detailed chemical structures, metabolic stability tables, and molecular docking simulation. Figures illustrate the structural differences between activators and inhibitors, while enzyme activity data (EC50 and IC50 values) validate the authors’ hypotheses. However, the study lacks a direct comparison of docking scores, making it challenging to contextualize binding efficiency across compounds. Nonetheless, YF2's successful docking into the p300 bromodomain binding site, along with its SAR insights, provides a solid foundation for future optimization of HAT modulators, offering promising therapeutic avenues for treating neurodegenerative diseases like Alzheimer’s and certain cancers.

      Introduction:

      The introduction effectively sets the stage for the study by clearly outlining the importance of histone acetyltransferases (HATs), particularly p300, in epigenetic regulation and its relevance to diseases such as Alzheimer’s and cancer. It provides a well-structured explanation of how histone acetylation affects gene expression and protein synthesis, emphasizing the therapeutic potential of targeting p300. The authors also successfully highlight the gap in current research, noting the limitations of histone deacetylase (HDAC) inhibitors and the need for more selective HAT modulators. This thoughtful framing makes a compelling case for why their work on designing novel small molecules to modulate p300 activity is both innovative and necessary. The inclusion of the background information on the structural domains of p300 and its functional overlap with CBP adds further depth, helping readers grasp the enzyme’s complexity and prodrug potential.

      There are a few areas for improvement though. While the introduction presents a strong scientific rationale, it could benefit from a more streamlined discussion of the p300/CBP structural features, as certain sections verge on being overly technical without immediate relevance to the study’s aims. Although the authors mention previous HAT activator scaffolds like CTPB, they do not sufficiently explain their limitations beyond solubility and permeability, missing an opportunity to underscore how their new compounds address these shortcomings. A clearer statement of the study’s specific hypotheses, beyond the general goal of identifying p300 modulators, would strengthen the narrative and better guide the reader into the results section. Overall, the introduction is solid and informative but could benefit from slight refinement for focus and impact.

      Results:

      The results section presents a clear and methodical exploration of newly synthesized N-phenylbenzamide analogs designed to modulate p300 activity. The study effectively categorizes these compounds into activators (YF2, RA010160, RA010168, RA010900) and inhibitors (JF1, JF10, JF16), providing enzyme activity data (EC50 and IC50 values) for histone 3 acetylation at lysine 18 and 27. Notably, YF2 emerged as a strong p300 activator, showing EC50 values of 155.01 nM (K18) and 72.54 nM (K27). The figures, such as Figure 1 and Table 1, are clear and easy to interpret, directly supporting the authors’ claims. Also, the metabolic stability tables highlight YF2’s limitations, revealing a poor half-life of 10 minutes in murine and 4.35 minutes in human liver microsomes, pointing to the need for further optimization.

      Despite these strengths, the results section has some limitations. While the structure-activity relationship (SAR) analysis effectively links molecular modifications to biological activity, like how smaller alkyl groups promote activation and longer, branched chains drive inhibition, there is a lack of direct docking score comparisons. This omission makes it challenging to fully contextualize YF2’s binding efficiency relative to other compounds. Furthermore, while YF2’s molecular docking into the p300 bromodomain is visualized and described, a more quantitative comparison of binding affinities would strengthen the conclusions. Overall, the results are well-supported by data, but additional docking metrics and a clearer link between metabolic findings and compound design strategies would enhance the section’s impact.

      Discussion:

      The discussion section effectively describes the findings within the broader context of histone acetyltransferase (HAT) research, emphasizing the therapeutic significance of p300 modulators. The authors highlight how their study builds upon previous work involving small-molecule HAT activators like CTPB and CTB, which were hindered by low potency and poor pharmacokinetics. By designing N-phenylbenzamide analogs, they address these limitations and identify both p300 activators (YF2, RA010168, RA010900) and inhibitors (JF1, JF10, JF16), advancing the field by offering a new chemical framework with improved activity. The paper stresses the relevance of HAT activation as a promising strategy for enhancing histone acetylation, particularly for neurodegenerative diseases like Alzheimer’s and contrasting it with the more commonly studied HDAC inhibition. This shift from HDAC to HAT targeting reflects a nuanced approach to epigenetic drug discovery.

      The discussion could benefit from more direct comparisons to the potency and pharmacokinetics of prior compounds like CTPB and CTB to better highlight the progress made. While the paper acknowledges YF2's strong p300 activation profile, it downplays its poor metabolic stability, mentioning it only as a future optimization target without exploring strategies for improvement. Although the structure-activity relationship (SAR) insights are valuable for linking side chain and alkyl group modifications to compound behavior, the discussion stops short of offering predictive models or design principles for future analogs. A more critical reflection on the challenges of balancing activation potency with metabolic stability would strengthen the discussion’s impact. The section solidly contextualizes the research but could benefit from deeper analysis of the study’s limitations and clearer comparisons to previous findings.

      Suggestions:

      This paper presents a strong foundation in the development of p300 histone (HAT) modulators, with the key discovery of N-phenylbenzamide analogs that act as either activators or inhibitors; however, a clearer hypothesis regarding the mechanistic underpinnings of how specific structural changes drive either activation or inhibition would sharpen the study’s impact.

      The results section effectively supports the study's claims through clear data presentation, including well-labeled figures and tables, but one notable gap is the lack of docking score comparisons via graphing tools, which limits the ability to fully contextualize YF2’s binding efficiency relative to other analogs. Including this data would provide a more robust evaluation of each compound’s molecular interaction with p300, further reinforcing the SAR analysis. These visual comparisons, such as graphs mapping SAR trends or docking results, would enhance the clarity and impact of the presented data.

      The discussion successfully contextualizes the study within the broader scope of HAT research, contrasting the new analogs with previous compounds like CTPB and CTB; however, the discussion does not fully address the poor metabolic stability of YF2, mentioning it briefly without proposing solutions. Suggesting strategies, like pro-drug approaches, targeted structural modifications, or lipid nanoparticle (LNP) delivery, would strengthen the discussion’s practical relevance. While the SAR insights are well-documented, the paper stops short of exploring why certain side-chain modifications shift compounds from activators to inhibitors, beyond size considerations. A speculative explanation based on molecular modeling or enzyme dynamics would add depth to the analysis.

      While the study employs appropriate methods of molecular docking, cell-free enzymatic assays, and metabolic profiling, there are clear areas for improvement. The lack of in vivo validation leaves a critical gap, as the compounds' efficacy and toxicity remain untested in a physiological context, which is necessary for drug development. Addressing YF2’s instability is also crucial, as the current data raise concerns about its drug viability. Overall, the paper presents innovative findings and expands the field of p300 modulation, but revisions should focus on providing strategies for improving YF2’s stability, including more comparative docking data, and offering deeper mechanistic insights into the activator and inhibitor behavior of N-phenylbenzamide analogs. With these enhancements, the study would be a strong candidate for publication in high-impact journals like the Journal of Medicinal Chemistry or ACS Chemical Biology.

    1. On 2025-03-27 18:10:43, user Luciano Marcon wrote:

      I would like to respectfully point out a misrepresentation regarding our work cited as reference [16] (Raspopovic et al., 2014).

      In your manuscript, you write:<br /> “In contrast, many studies with realistic biological geometries either neglect growth or fail to explore how growth rate influences the emergence of patterns [16, 20, 21, 22].”

      However, this characterization does not accurately reflect our study. In Raspopovic et al. (2014), we explicitly analyzed the influence of growth on pattern formation, as shown in Figure 3A and Figure 23 of the supplementary data. This analysis was based on a limb growth model derived from experimental clonal data (see also Marcon et al., 2011), and understanding how growth modulates pattern emergence was one of the central aims of that work.

      We kindly ask you to consider correcting this point to more accurately reflect the content and focus of our study.

    1. On 2021-05-21 14:14:59, user R Greg Thorn wrote:

      Nice work and potentially an important concept in invasion biology, but please clarify the identification step of your bioinformatics pipeline. An approximate match in QIIME/UNITE is not an identification. Talaromyces marneffei is (we hope!) unlikely to be a common fungus in Illinois soils. It is a serious human pathogen that is, so far as we know, restricted to southeast Asia, centered on Laos, Cambodia and Vietnam. Some other IDs are equally suspect. Please don't let this get into print.

    1. On 2016-01-07 17:12:02, user Charles C. Mann wrote:

      Interesting paper. I suspect the Luckey estimate (1972:1292) is actually taken from an earlier Luckey paper (Luckey, T.D. 1970. Gnotobiology is Ecology. American Journal of Clinical Nutrition 23:1533-40), see table 1.

    1. On 2019-09-18 06:54:36, user Jeremiah Stanley wrote:

      Hello authors. It was quite a brave attempt to explore the role of 5HT in macrophages. I have a logical question. There is an interplay of 5HT2B and 5HT7 in modulating the macrophage. So when an antagonist is used against a particular receptor, the 5HT in the medium will be acting more on the other receptor. For example here, the antagonist to 5HT2B was used. without the antagonist, 5HT would be acting on both 2B and 7. But after antagonist addition, 5HT will be acting on only 7. Can this be a reason for the antagonist to not nullify the action of the agonist? Interplay of receptors?

    1. On 2016-05-16 14:14:19, user gerton.lunter wrote:

      Tx. Yes, that question has been bugging me too. FW/BW is not possible as far as I can see; but some version of conditional sampling may be possible, although it's like to be approximate (the only algorithm I know for exact conditional sampling uses FW/BW...)

    1. On 2015-04-07 23:09:59, user aaron wrote:

      Creationists have been saying this for years. Man originated in northern Africa. After the flood, the sons of Japeth migrated north into Europe. Their skin, while darker than now, simply adapted to the environment over years. I thought this was common sense. Guess not!

    1. On 2019-08-28 13:04:17, user Filipe wrote:

      Dear Nathan C. Medd and colaborators, congratulations for your study it's really interesting. I'd like to pointing only one little mistake in figure of pg 34 about Mogami Viruses structure. According with the image, the glycoprotein signature it's present on ORF 3 (with 685 AA), but, according with a fast BLAST analysis, this ORF represents an hypothetical nucleoprotein and the glycoprotein signature it's present on ORF 1 (with 1157 AA) which make sense in orientation when we compare the Mogami virus structure with Shayang Fly Virus 1 structure (Glyco-VP2-Nucleo-RdRp).

      Again, congratulations for this study.

      All the best.